Cancer and Blood Diseases Institute

Publications

Abdullah, S; Sabulski, A; Hudda, Z; Ziady, A; Luebbering, N; Giordullo, L; Odegard, E; Blackard, JT; Kleiboeker, S; Altrich, M; Jodele, S; Seif, AE; Davies, SM; Laskin, BL. Susceptibility to BK polyomavirus-associated hemorrhagic cystitis in children undergoing allogeneic transplant. Haematologica. 2025; 110(2):527-531.

Abdullah, S; Sabulski, A; Hudda, Z; Ziady, AG; Luebbering, N; Langenberg, L; Odegard, E; Blackard, JT; Kleiboeker, S; Jodele, S; Seif, AE; Davies, SM; Laskin, B. Bkpyv Replication Kinetics and Association with Hemorrhagic Cystitis in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2025; 31(2):s515-s516.

Abid, MB; Wudhikarn, K; Ye, Q; Martens, M; Mirza, A-S; Gowda, L; Devarakonda, S; Efebera, Y; Boghdadly, ZE; Dandoy, C; Murthy, H; Perales, M-A; Huppler, A; Auletta, J. Infections in patients with relapsed refractory multiple myeloma receiving idecabtagene vicleucel therapy: A real-world analysis from CIBMTR. Blood. 2025; 146(Supplement 1):716.

Abts, MF; Silva Carmona, MD; Baker, KS; Ballard, S; Genatossio, A; Lane, A; Robinson, PD; Allen, JL; Koo, J; Davies, SM; Goldfarb, SB. Comparisons Between Multiple Breath Washout and Standard-of-Care Spirometry in Children Undergoing Allogenic Hematopoietic Stem Cell Transplant: A Transpire Study. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a5125-a5125.

Adeyemi, A; Gross, AM; Baldwin, A; Dombi, E; Widemann, BC; Sint, KJ. Selumetinib in pediatric patients with neurofibromatosis type 1 and plexiform neurofibroma: Propensity score analysis of SPRINT vs. natural history control arm. Neuro-Oncology Advances. 2025; 7(1):vdaf101.

Agarwal, P; Sampson, A; Hueneman, K; Choi, K; Jakobsen, NA; Uible, E; Ishikawa, C; Yeung, J; Bolanos, L; Zhao, X; Galloway-Pena, J; Byrd, JC; Vyas, P; Starczynowski, DT. Microbial metabolite drives ageing-related clonal haematopoiesis via ALPK1. Nature. 2025; 642(8066):201-211.

Aggarwal, RK; Sidoli, S; Wang, J; Sahu, S; Sanawar, R; Gupta, V; Aluri, S; Sukrithan, V; Vegivinti, CTR; Zavras, PD; Lafave, LM; Cheng, H; Verma, A; Zou, Y. Smoking-Associated Carcinogen-Induced Inflammation Promotes Lung Carcinogenesis via IRAK4 Activation. Clinical Cancer Research. 2025; 31(4):746-755.

Ahmari, N; Choi, K; Wu, J; Rizvi, TA; Jackson, M; Kershner, LJ; Kim, M-O; Zhang, X; Dombi, E; Shern, J; Hildeman, DA; Ratner, N. Daytime SHP2 inhibitor dosing, when immune cell numbers are elevated, shrinks neurofibromas. Life Science Alliance. 2025; 8(12).

Alexander, JL; Dávila Saldaña, BJ; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, J; Ebens, CL; Cowan, MJ; Petrovic, A; Pai, S-Y; Burroughs, LM. Hematopoietic Cell Transplantation for Wiskott-Aldrich syndrome: A PIDTC Report. Blood advances. 2025.

Alexander, JL; Saldana, BJD; Brazauskas, R; Dammalapati, SG; Griffith, LM; Shah, AJ; Shimano, KA; Ochs, HD; Bleesing, JJ; Ebens, CL; Petrovic, A; Pai, S-Y; Burroughs, LM; Chan, A. Hematopoietic Cell Transplantation for Wiskott-Aldrich Syndrome - Impact of Age, Donor, and Infection: A Pidtc Report. Transplantation and Cellular Therapy. 2025; 31(2):s39-s41.

Alharbi, S; Merkle, S; Hammill, AM; Waters, AM; Le Cras, TD. RAS Pathway Mutations and Therapeutics in Vascular Anomalies. Pediatric Blood and Cancer. 2025; 72(5):e31605.

Almodallal, Y; Whitehurst, D; Way, SS; Koo, J; Kumar, AR. Emapalumab for Maladaptive Interferon-γ-Mediated Inflammation in Drug Reaction With Eosinophilia and Systemic Symptoms Complicating First-Line Antituberculosis Therapy. Pediatric Blood and Cancer. 2025; 72(12):e32052.

Almohtasib, J; Indelicato, DJ; Paulino, AC; Mihalcik, S; Lee, J; Ermoian, R; Chang, JH-C; Kwok, Y; Perentesis, J; Perkins, SM; Hill-Kayser, C; Zeina, W; Laack, NN; Yock, TI; Gargollo, PC. Assessing Acute and Long-Term Toxicities of Proton Radiation Therapy in Pediatric Pelvic Tumors: Findings From the Pediatric Proton Consortium Registry. Pediatric Blood and Cancer. 2025; 72(10):e31811.

Al-Samkari, H; Kasthuri, RS; Mager, H-J; Zhou, JY; Serra, MM; Samuelson-Bannow, BT; Van Doren, LN; Piccirillo, JF; Clancy, MS; Mccrae, KR; Mei-Zahav, M; Von Drygalski, A; Olitsky, S; Faughnan, ME. Standardization of Terminology, Definitions, and Outcome Criteria for Bleeding in Hereditary Hemorrhagic Telangiectasia: International Consensus Report. American Journal of Hematology. 2025; 100(10):1813-1827.

Ambrose, EE; Kidenya, BR; Smart, LR; Manjurano, A. Alpha+ Thalassemia in Northwestern Tanzania: Molecular and Hematological Insights From Newborn Screening. Journal of Blood Medicine. 2025; 16:241-250.

Ambrose, EE; Sabuni, PA; Jason Iii, DP; Ware, RE; Makubi, AN; Smart, LR. Hydroxyurea to decrease stroke risk in children with sickle cell anemia: a systematic review and meta-analysis. Blood Global Hematology. 2025; 1(1).

Ammari, O; Shah, M; Elgammal, Y; Husami, A; Kalfa, TA; Gollamudi, J. When a Trait Becomes a Disease: A Rare Hematologic Overlap of Sickle Cell Trait and Hereditary Spherocytosis. American Journal of Hematology. 2025.

Anandappa, A; Trivedi, V; Bones, M; Raval, J; Hefner, R; Wooten, A; Bowman, R; Levine, R; Starczynowski, D; Miles, L. RAS G12 and Q61 codon mutations confer distinct disease characteristics in Acute Myeloid Leukemia and exhibit differential response to RAS(ON) inhibitor RMC-7977. Blood. 2025; 146(Supplement 1):3229-3229.

Andresen, F; Myers, KC; Guttierez, A; Schwarz, D; Goldberg, B; Weller, E; Reilly, C; Brundige, K; Loveless, S; Cheng, L; Lindsley, C; Shimamura, A. CONCORDANCE OF SOMATIC GENETIC TESTING IN BLOOD VS. BONE MARROW IN SHWACHMAN-DIAMOND SYNDROME. EJC Paediatric Oncology. 2025; 6:100332.

Appell, LE; Baggott, C; Nguyen, K; Prabhu, S; Pacenta, H; John, S; Fabrizio, VA; Phillips, CL; Rossoff, J; Talano, J-A; Mackall, CL; Laetsch, TW; Mcnerney, K; Schultz, LM. Liberalizing hospital proximity requirements for children/young adults with low-burden B-ALL receiving tisagenlecleucel. Blood advances. 2026; 10(1):106-110.

Appell, L; Modi, A; Baggott, C; Nguyen, K; Prabhu, S; Pacenta, HL; Fabrizio, VA; Phillips, CL; Rossoff, J; Stefanski, HE; John, S; Laetsch, TW; Mcnerney, KO; Schultz, L. Liberalizing Requirements for Hospital Proximity Post-CD19 CAR for Children with Low Burden B-ALL at Infusion. Transplantation and Cellular Therapy. 2025; 31(2):s230-s231.

Armstrong, AE; Daw, NC; Renfro, LA; Geller, JI; Kalapurakal, JA; Khanna, G; Paulino, AC; Perlman, EJ; Ehrlich, PF; Gow, KW; Warwick, AB; Grundy, PE; Fernandez, CV; Mullen, EA; Dome, JS. Treatment of focal anaplastic Wilms tumor: A report from the Children's Oncology Group AREN0321 and AREN03B2 studies. Cancer. 2025; 131(2):e35713.

Arnold, DE; Kaviany, S; Aluri, J; Calvo, KR; Mehta, SS; Tobin, JM; Schuettpelz, L; Saucier, N; Schmitz, EG; Murguía-Favela, L; Pai, S-Y; Bednarski, JJ; Connelly, JA; Cooper, MA. Clinical Characteristics, Management, and Hematopoietic Cell Transplantation of Patients with TLR8 Gain-of-Function. Blood advances. 2025.

Arnold, DE; Leiding, JW; Logan, B; Marsh, RA; Griffith, LM; Grunebaum, E; Murguía-Favela, L; Mallhi, K; Chellapandian, D; Deal, CL; Torgerson, T; Malech, HL; Kang, EM; Parikh, S. Umbilical Cord Blood Transplantation Provides an Alternative for Patients With Chronic Granulomatous Disease Lacking HLA-Matched Donors: A PIDTC Report. Transplantation and Cellular Therapy. 2026; 32(1):89.e1-89.e10.

Ashraf, A; Murphey, C; Sper, C; Webster, A; Lane, A; Mesa, S; Garcia, F; Perez, R; Chamblin, C; Davies, SM; Khandelwal, P. Underlying Diagnosis and RBC Transfusions Increase HLA Antibodies in Children before Hematopoietic Stem Cell Transplantation. Transplantation and Cellular Therapy. 2025.

Ashraf, A; Davies, SM; Jodele, S; Sabulski, A. A 10-Year History of Graft Failure in Pediatric Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(2):s148-s149.

Ashraf, A; Murphey, C; Sper, C; Webster, A; Lane, A; Mesa, S; Garcia, F; Perez, R; Chamblin, C; Davies, SM; Khandelwal, P. Male Gender and Underlying Diagnosis Predisposes to Increased HLA Antibody Burden in Children before Allogeneic Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(2):s147.

Ashraf, A; Lake, KE; Myers, KC; Towe, C; Cooper, R; Edwards, SL; Hils, B; Davies, SM; Koo, J. Frequent Pulmonary Complications after Allogeneic Hematopoietic Stem Cell Transplant: A Brief Transpire Report. Transplantation and Cellular Therapy. 2025; 31(2):s149-s150.

Avery, R; Listernick, R; De Blank, P; Liu, G; Ferner, R; Gutmann, D; Fisher, M; Team, N-ONHS. 005 Baseline clinical characteristics of newly diagnosed optic pathway gliomas associated with NF1: results from the international multicenter NF1-OPG Natural History Study. Journal of AAPOS. 2025; 29(4):104287.

Avery, RA; Gross, AM; Cousineau-Krieger, C; Keenan, TDL; Mcmanus, T; Dallas, CJ; Hampton, C; Baldwin, A; Jin, F; Heisey, K; Bishop, RJ; Fisher, MJ; Widemann, BC; Magone, MT. Long-term Ocular Safety in Children Treated with Mitogen-Activated Protein Kinase Pathway Inhibitor Therapy. Ophthalmology (Rochester, Minn.). 2026; 133(2):291-294.

Azucenas, C; Voulgaridou, A; Elgammal, Y; Ntoumaziou, A; Risinger, M; Seu, K; Sen, S; Kottyan, L; Salomonis, N; Kalfa, T. Erythroid-specific, inducible CDAN1∆/∆ mouse model phenocopies congenital dyserythropoietic anemia type-la. Blood. 2025; 146(Supplement 1):186-186.

Babic, I; Bryan, N; Cunningham, C; Sampson, A; Starczynowski, D; Nurmemmedov, E. MICRO-TAG enzyme complementation enables quantification of cellular drug-target engagement in temperature series. SLAS Discovery. 2026; 38:100291.

Babic, I; Bryan, N; Cunningham, C; Sampson, A; Starczynowski, D; Nurmemmedov, E. Abstract 5480: Live cell real-time quantification of drug-target engagement for rapid drug discovery. Cancer Research. 2025; 85(8_Supplement_1):5480-5480.

Bacha, J; Brown, D; Geller, J; Oesterheld, J; Thompson, P; Kim, A; Mcmanus, M; Kanekal, S; Leggas, M; Lopez, L; Sankar, N; Yam, N; Wagner, L. Abstract LB266: A multicenter phase 1-2a clinical study of Orotecan® (oral irinotecan HCl, VAL-413) in patients with recurrent pediatric solid tumors. Cancer Research. 2025; 85(8_Supplement_2):lb266-lb266.

Badar, T; Kumar, M; Kusne, Y; Lasho, T; Foran, J; Murthy, H; Kharfan-Dabaja, M; Chlon, T; Gangat, N; Alkhateeb, H; Ferrer, A; Litzow, M; Al-Kali, A; Patnaik, M. Decoding DDX41: Clinical impact of germline and somatic mutations in 77 high-risk myeloid neoplasm patients. Blood. 2025; 146(Supplement 1):1442.

Bahakel, H; Spieker, AJ; Hayek, H; Schuster, JE; Hamdan, L; Dulek, DE; Kitko, CL; Stopczynski, T; Batarseh, E; Haddadin, Z; Englund, JA; Munoz, FM; Danziger-Isakov, L; Halasa, N. Immunogenicity and Reactogenicity of High- or Standard-Dose Influenza Vaccine in a Second Consecutive Influenza Season. Journal of Infectious Diseases. 2025; 231(1):e123-e131.

Bartlett, AL; Ramos, KN; Bartlett, JR; Ramos, KS; Luebbering, N; Myers, KC; Mehta, PA; Davies, SM. LINE-1 Retroelement Activation and Neuroinflammation in Persons With Fanconi Anemia. Pediatric Blood and Cancer. 2025; 72(12):e32081.

Bauchat, A; Peterson, A; Ahn, KW; Mehta, PA; Phillips, CL; Schultz, KR; Sharma, A; Broglie, L; Qayed, M. Impact of Graft Versus Host Disease Following Allogeneic Hematopoietic Cell Transplantation on Leukemia Free Survival in Hematologic Malignancies: A CIBMTR Analysis. Transplantation and Cellular Therapy. 2025; 31(2):s60-s61.

Bedard, MC; Rivera-Cruz, CM; Chihanga, T; Vonhandorf, A; Tang, AL; Zender, C; Weirauch, MT; Ferris, R; Wise-Draper, TM; Adam, M; Wells, SI. A Single-Cell Transcriptome Atlas of Epithelial Subpopulations in HPV-Positive and HPV-Negative Head and Neck Cancers. Viruses. 2025; 17(4).

Belton, TD; Steinway, CM; Teng, O; Shults, J; Barakat, LP; Aygun, B; Appiah-Kubi, A; Crosby, LE; Niss, O; Andemariam, B; Johnson, TB; Rubin, DM; Smith-Whitley, KM; Jan, S. The Community Health Workers and Mobile Health for Emerging Adults Transitioning Sickle Cell Disease Care (COMETS) Trial: Protocol for a Randomized Controlled Trial. JMIR Research Protocols. 2025; 14:e69239.

Bender, J; Davies, SM; Myers, KC; Benoit, SW. Beyond Survival: Assessing Renal and Cardiovascular Health in Fanconi Anemia Adolescents and Young Adults Post-Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(2):s375-s376.

Benedetti, DJ; Cost, NG; Ehrlich, PF; Evageliou, N; Fialkowski, E; Parsons, LN; Vallance, KL; Renfro, LA; Hong, AL; Aldrink, JH; Treece, AL; Dome, JS; Geller, JI; Mullen, EA. Updated favourable-histology Wilms tumour risk stratification: rationale for future Children's Oncology Group clinical trials. Nature Reviews Urology. 2025; 22(11):775-788.

Bhatt, NS; Lehmann, L; Dandoy, CE; Auletta, JJ; Badia, P; Ballard, SA; Blacken, R; Daraiseh, NM; Desmond, C; Dunseath, C; Tarquini, S; Phelan, R; Pai, A; Rotz, S. Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation Part I: Integrative Analysis of Mental Health, Psychosocial Stressors, and Support Mechanisms. Transplantation and Cellular Therapy. 2025; 31(7):456.e1-456.e16.

Bhatt, N; Hellewell, EM; Ng, K; Gooley, TA; Taylor, AO; Hong, S; Sung, A; Ahmed, N; Morey, C; Fitzmaurice, S; Yingling, S; Edgar, C; Browning, A; Lee, CJ. Real-World Assessment of Patient Adherence to the Late Effects Screening Recommendations Among Hematopoietic Cell Transplantation Survivors. Transplantation and Cellular Therapy. 2025; 31(2):s364-s365.

Bischoff, LJ; Schrenk, S; Soroko, K; Sherpa, C; Arasu, A; Reynaud, D; Boscolo, E. Expression of mutant TIE2 p.L914F during mouse development causes embryonic lethality and defects in vascular remodeling. Developmental Dynamics. 2025.

Bleesing, J. The Fas-mediated apoptosis assay: From concept to clinical application. Journal of Immunological Methods. 2025; 537:113812.

Blumenstock, JA; Boge, C; Shuster, S; Li, Y; Seif, AE; Green, MD; Michaels, MG; Alexander, JL; Ardura, MI; Auletta, J; Kajon, AE; Grimley, M; Danziger-Isakov, LA; Fisher, BT. 633. Incidence and Outcomes of Pediatric Allogeneic Hematopoietic Cell Transplant (allo-HCT) Recipients Under Surveillance and Not Under Surveillance for Human Adenovirus (HAdV) in the Post-HCT Period. Open Forum Infectious Diseases. 2025; 12(Supplement_1):ofae631.198.

Boldt, A; Bender, J; Jodele, S; Davies, SM; Benoit, SW. Differential Filtration of Macromolecules: A Novel Indicator of Mortality Risk in Pediatric HSCT Patients. Transplantation and Cellular Therapy. 2025; 31(2):s145-s146.

Borate, U; Pugh, K; Waller, A; Welkie, RL; Huang, Y; Bewersdorf, JP; Stahl, M; Dezern, AE; Platzbecker, U; Sekeres, MA; Bennett, JM; List, AF; Brunner, AM; Zeidan, AM. Reducing clinical trial eligibility barriers for patients with MDS: an icMDS position statement. Blood. 2025; 145(13):1369-1381.

Bosticardo, M; Dobbs, K; Delmonte, OM; Martins, AJ; Pala, F; Kawai, T; Kenney, H; Magro, G; Rosen, LB; Yamazaki, Y; Villa, A; Rosenzweig, SD; Pittaluga, S; Notarangelo, LD. Multiomics dissection of human RAG deficiency reveals distinctive patterns of immune dysregulation but a common inflammatory signature. Science immunology. 2025; 10(103):eadq1697.

Boucher, A; Cole, OB; Desai, PC; Donald, C; Fasipe, TA; Quinn, CT; Kennedy Lesch, J; Thompson, AA. ASH's Commitment to SCD: Building on 10 Years of Progress. Blood advances. 2025.

Boucher, AA; Dayton, VJ; Pratt, AR; Nassar, NN; Elgammal, Y; Kalfa, TA. Three-generation female cohort with macrocytic anemia and iron overload. American Journal of Hematology. 2025; 100(1):133-138.

Bowers, K; Benoit, S; Rose, J; Beck, AF; Folger, AT; Calhoun, TN; Day, ME; Lovell, A; Amin, M. High Household Transmission Among Asymptomatic Contacts Across Pandemic Waves in Cincinnati, Ohio. Epidemiologia. 2025; 6(4).

Brown, A; Pommert, L. GATA Lot to Learn: Decoding the Drivers of Down Syndrome-Associated Acute Leukemias. The Hematologist. 2025; 22(4).

Brown, M; Grassia, K; Miller, J; Hall, E; Dewan, M; Dandoy, C; Zhang, B; Wagner, AF. 1187: ECMO IN PEDIATRIC ONCOLOGIC AND HEMATOPOIETIC STEM CELL TRANSPLANT PATIENTS: A COMPARATIVE ANALYSIS. Critical Care Medicine. 2025; 53(1).

Brumm, VL; Kidd, SA; Logan, BR; Chunara, F; Heimall, J; Griffith, LM; Kohn, DB; Sanchez, L; Bednarski, JJ; Martinez, C; Pulsipher, MA; Puck, JM; Cowan, MJ; Shah, AJ. Neurodevelopmental outcomes following hematopoietic cell transplantation for patients with severe combined immunodeficiency (SCID): A PIDTC study. Journal of Human Immunity. 2026; 2(1):e20250163.

Butt, H; Dwivedi, P; Davila Saldana, B; Kochis, S. Etiologies and clinical predictors of pediatric eosinophilia: A retrospective analysis from a tertiary care center. Blood. 2025; 146(Supplement 1):6554-6554.

Cai, M; Adam, M; Guo, F; Zheng, Y. Abstract 1596: Tumor-derived RAC1A159V gain-of-function mutation promotes an immunosuppressive tumor microenvironment and represses response to immune checkpoint inhibitors. Cancer Research. 2025; 85(8_Supplement_1):1596-1596.

Cai, M; Adam, M; Duan, X; Guo, F; Zheng, Y. Tumor-derived RAC1A159V mutation promotes an immunosuppressive microenvironment that represses response to immune checkpoint inhibitor. Science Advances. 2025; 11(44):eaea1212.

Campbell, ME; Stutzman, S; Primeaux, S; Sida, D; Lee, M; Shah, AT; Sadanand, A; Sokol, E; Collins, NB; Turpin, B; Rakheja, D; Chen, KS; Gerber, DE; Koh, AY. Feasibility of Atezolizumab in Combination With Chemotherapy for Children With Relapsed or Refractory Solid Tumors. Pediatric Blood and Cancer. 2025; 72(12):e32046.

Canaud, G; López-Gutiérrez, JC; Hammill, A; Weibel, L; Niglis, S; Paul, M; Papadimitriou, A; Wroclawska, M; Caro, N; Adams, D. 118: Randomized, Double-Blind, Phase 2 Study of Alpelisib in Pediatric and Adult Patients With PIK3CA-Related Overgrowth Spectrum (PROS) Journal of Investigative Dermatology. 2025; 145(3):e29.

Cantrell, R; Feldman, HA; Rosenfeldt, L; Ali, A; Gourley, B; Sprague, C; Leino, D; Crosby, J; Revenko, A; Monia, B; Waggoner, SN; Palumbo, JS. Prothrombin prevents fatal T cell-dependent anemia during chronic virus infection of mice. JCI Insight. 2025; 10(4).

Cha, E; Mihalcik, SA; Indelicato, DJ; Laack, NN; Ermoian, RP; Mangona, VS; Perkins, SM; Wolden, SL; Lee, JY; Perentesis, JP; Eaton, BR; Le, HV; Paulino, AC; Yock, TI. Outcomes of Patients with Intracranial Germinoma Enrolled on the Pediatric Proton Photon Consortium Registry. International Journal of Radiation Oncology Biology Physics. 2025; 123(1):e144-e145.

Chan, AK; Susen, S; Khoo, L; Von Drygalski, A; Oldenburg, J; Shen, M-C; Peyvandi, F; Tarango, C; Chowdary, P; Mamikonian, L; Palmborg, H; Dumont, J; Santagostino, E; Hermans, C. Perioperative Management with Efanesoctocog Alfa in Adults, Adolescents, and Children with Severe Hemophilia A in the Phase 3 XTEND Clinical Program. Hamostaseologie. 2025; 45:s57-s58.

Chandra, S; Greis, KD; Chutipongtanate, S; Luebbering, N; Webster, A; Poisson, K; Fisher, K; Smiley, K; Marsh, RA; Jordan, MB; Davies, SM. Novel CSF Biomarkers for facilitating diagnosis of CNS-HLH from other Neuroinflammatory Disorders. Blood advances. 2025.

Chandrakasan, S; Allen, CE; Bhatla, D; Carter, J; Chien, M; Cooper, R; Draper, L; Eckstein, OS; Hanna, R; Hays, JA; Walkovich, KJ; Yee, JD; Zoref-Lorenz, A; Behrens, EM. Emapalumab Treatment in Patients With Rheumatologic Disease-Associated Hemophagocytic Lymphohistiocytosis in the United States: A Retrospective Medical Chart Review Study. Arthritis & Rheumatology. 2025; 77(2):226-238.

Chang, X; Li, W; Matsui, S; Huynh, C; Erickson, C; Guo, F; Cederquist, GY; Studer, L; Iwafuchi, M; Shillington, A; Chronis, C; Tchieu, J. ZMYND11 functions in bimodal regulation of latent genes and brain-like splicing to safeguard corticogenesis. Nature Communications. 2025; 16(1):9010.

Chang, M; Semakula, D; Little, JA; Kanter, J; Manwani, DG; Owusu-Ansah, A; Cohen, AJ; Cronin, RM; Desai, PC; Strouse, JJ; Alvarez, OA; Saif Ur Rehman, S; Shah, S; Lanzkron, SM. Grandchildren of GRNDaD: Shifts in disease-modifying therapy at the adolescent transition in sickle cell disease. British Journal of Haematology. 2025; 207(3):1070-1075.

Chang, E; Rubinstein, J; Pommert, L. WU Hoo! The Promise of Allogeneic WU-CART-007 in Relapsed/Refractory T-Cell Malignancies. The Hematologist. 2025; 22(5).

Chen, F; Liu, X; Zhong, X; Chen, X; Nicholson, E; Liu, K; Chen, H; Lin, Y; Shu, Y; Zhou, W; Schuurmans, CJ; Lu, QR. Neurons derived from NeuroD1-expressing astrocytes transition through transit-amplifying intermediates but lack functional maturity. Science Advances. 2025; 11(30):eadw9296.

Chen, Z; Zeng, C; Yang, L; Che, Y; Chen, M; Sau, L; Wang, B; Zhou, K; Chen, Y; Qing, Y; Weng, H; Xiao, G; Deng, X; Chen, J. YTHDF2 promotes ATP synthesis and immune evasion in B cell malignancies. Cell. 2025; 188(2):331-351.e30.

Chi, M; Malik, P. An engineered β-globin homology donor reveals insights into β-globin expression and betters HDR. Molecular Therapy. 2025; 33(4):1308-1309.

Chiang, S; Yang, L; Akeno, N; Owsley, E; De Jesus, A; Goldbach-Mansky, R; Marsh, R; Bleesing, J. Validation of an Interferon Type I Score Test on the Nanostring nCounter Platform. Journal of Human Immunity. 2025; 1(CIS2025).

Chiang, S; Akeno, N; Owsley, E; Verbsky, J; Ibrahimova, A; Bleesing, J; Marsh, R. Clinical and Analytical Validation of a NOD2 Functional Test for XIAP/XLP2 Diagnosis. Journal of Human Immunity. 2025; 1(CIS2025).

Chiang, SCC; Owsley, E; Husami, A; Akeno, N; Cobb, CM; Yang, L; Marsh, RA; Myers, KA; Rubin, TS. Case Report: A patient with a novel heterozygous IRF8 variant with repeated infection and immune-mediated organ disease, but without disseminated mycobacterial disease despite BCG immunization. Frontiers in Immunology. 2025; 16:1654617.

Chiang, SCC; Yang, L; Owsley, E; Husami, A; Akeno, N; Cobb, C; Hartog, NL; Elizalde, A; Seroogy, CM; Blanchard-Rohner, G; Marsh, R; Bleesing, J; Jordan, MB; Marwaha, AK. Lipopolysaccharide-responsive and beige-like anchor protein (LRBA) functional deficiency caused by biallelic LRBA missense variants characterized by Evans syndrome or colitis. Journal of Allergy and Clinical Immunology. 2025; 156(2):270-278.

Childress, A; Koch, A; Vallee, E; Steller, A; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Atypical Teratoid Rhabdoid Tumor. Journal of Molecular Pathology. 2025; 6(2):13.

Choaib, A; Azzam, M; Khawandi, J; Kawtharany, H; Hamarsha, Q; Alkhader, A; Nazzal, J; Alkasrawi, H; Khanfar, O; Bercovitz, R; Zia, A; Monagle, P; Betensky, M; Mustafa, R. Role in of primary VTE prophylaxis in pediatric patients in hospitalized and critically ill settings: A systematic review and meta-analysis. Blood. 2025; 146(Supplement 1):3137-3137.

Chohan, K; Feng, L; Cochran, H; Rosenberg, M; Isenalumhe, L; Yilmaz, E; Kim, S-H; Tiger, YK; Torka, P; Flanagan, H; Hamadani, M; Diefenbach, C; Bartlett, N; Ahmed, S. Real-world clinical outcomes with novel agent combination therapies for the frontline treatment of pediatric and adult advanced-stage Hodgkin lymphoma. Blood. 2025; 146(Supplement 1):1852-1852.

Choi, J; Koo, J. Yellow Fluorescent Protein Quenching Assay for Analyzing Odorant Receptor Activity. Methods in Molecular Biology. 2025; 2915:169-177.

Choi, J; Koo, J. Protein-Protein Interactions of Odorant and G Protein-Coupled Receptors: A BRET Analysis Approach. Methods in Molecular Biology. 2025; 2915:161-168.

Chowdhury, I; Jakobsen, ER; Krupski, M. A strongly degenerate fully nonlinear mean field game with nonlocal diffusion. Journal of Differential Equations. 2025; 440:113436.

Clough, CA; Cunningham, C; Philbrook, SY; Hueneman, KM; Sampson, AM; Choi, K; Greis, KD; Starczynowski, D. Characterization of E1 enzyme dependencies in mutant-UBA1 human cells reveals UBA6 as a novel therapeutic target in VEXAS syndrome. Leukemia. 2025; 39(8):1997-2009.

Cohen, RM; Craig, J; Omololu, SO; Tozzo, V; Smith, EP; Arbabi, S; Genco, M; Abplanalp, W; Thibault, D; Quinn, CT; Lindsell, CJ; Bergenstal, RM; Franco, RS; Higgins, J. 166-OR: Mean RBC Age (MRBC) Variation Accounts for the Predominance of Mismatch (MM) between Measured HbA1c (mA1c) and CGM-Derived Estimated HbA1c (eA1c) Diabetes. 2025; 74(Supplement_1).

Coleman, KD; Mckinley, K; Ellison, AM; Alpern, ER; Hariharan, S; Topoz, I; Wurtz, M; Nielsen, B; Cook, LJ; Morris, CR; King, AA; Baumann, A; Frankenberger, W; Brousseau, DC. Associations Between Pain Scores and Opioid Doses With Emergency Department Disposition and Return Visit Rates in Children With Sickle Cell Disease. Pediatric Blood and Cancer. 2025; 72(7):e31750.

Cook, E; Haacker, L; Chandra, S; Jordan, MB; Verkamp, B; Mccarthy, L; Rotz, SJ; Hammoud, MS; Pariury, H; Mckeone, D; Kumar, A. EBV-Associated T/NK-LPD Manifesting As HLH Cured By Nivolumab and Emapalumab, Avoiding the Need for Allogeneic HCT. Transplantation and Cellular Therapy. 2025; 31(2):s43.

Cook, E; Schulert, G; Grom, A; Towe, C; Burg, G; Marsh, R; Chandra, S. Experience with T Cell–Depleted Allogeneic HSCT for Refractory sJIA Associated with Lung Disease. Journal of Human Immunity. 2025; 1(CIS2025).

Cook, E; Rotz, SJ; Auletta, JJ; Bidgoli, A; Blacken, R; Johnson, D; Badia, P; French, K; Hartley, DM; Kent, GR; Schoettler, ML; Sampson, M; Dandoy, CE; Fitch, TJ. Central Venous Catheter Removal After Hematopoietic Stem Cell Transplant: A Review and Perspective. Pediatric Blood and Cancer. 2025; e70001.

Cook, E; Langenberg, L; Luebbering, N; Ibrahimova, A; Myers, KC; Sabulski, A; Dandoy, C; Lake, K; Ziady, A; Lane, A; Webster, A; Abdullah, S; Jodele, S; Davies, SM. Oxidative Stress Early After Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(3):135.e1-135.e10.

Costa, E; Ware, R; Tshilolo, L; Luzzatto, L. Thirty Years of Hydroxyurea for Sickle Cell Anemia - Scientific Progress, Global Health Gaps. New England Journal of Medicine. 2025; 393(16):1556-1559.

Costa, E; Ware, RE; Tshilolo, L; Makani, J; Leufkens, HGM; Luzzatto, L. Globalization in clinical drug development for sickle cell disease. American Journal of Hematology. 2025; 100(1):4-9.

Crary, S; Mack, J; Al-Huniti, A; Chang, V; Drolet, B; Hammill, A; Iacobas, I; Kelly, M; Winger, BA; Robledo, M; Blakesley, R; Patriquin, C; Mar, B; Sisk, B. ReInspire: A phase 2 study of mutant-selective PI3Kα inhibitor, RLY-2608, in adults and children with PIK3CA-related overgrowth spectrum and malformations driven by PIK3CA mutation. Blood. 2025; 146(Supplement 1):3092.

Crisler, K; Norris, R; Ketterl, T; Perentesis, J; Mcgrady, M. Social support and barriers to medication adherence among adolescents and young adults with leukemia and lymphoma. Blood. 2025; 146(Supplement 1):2706.

Curlee, MS; Siegel, A; Little, P; Toledo-Tamula, MA; Martin, S; Gross, AM; Yohe, ME; Aryavand, M; Frone, MN; Ney, GM; Stewart, DR; Wolters, PL. Wide Ranging Neurobehavioral Phenotype in Individuals With Costello Syndrome. American Journal of Medical Genetics, Part A. 2026.

Curlee, MS; Toledo-Tamula, MA; Baker, M; Wikstrom, D; Harrison, C; Rhodes, A; Fagan, M; Tibery, C; Wolters, PL; Widemann, BC; Gross, AM; Martin, S. A Mixed Methods Study of Medication Adherence in Adults with Neurofibromatosis Type 1 (NF1) on a Clinical Trial of Selumetinib. Cancers. 2025; 17(2).

D'alessandro, PR; Homanick, CE; Cooper, BD; Ferguson, K; Rutan, H; Pressey, JG. "From Drowning to Treading Water": Adolescents and Young Adults Living with Incurable and Indolent Metastatic Soft Tissue Sarcoma for More than Two Years. Cancers. 2025; 17(3).

Dandoy, CE; Auletta, JJ; Badia, P; Bidgoli, A; Daraiseh, NM; Desalvo, AM; Diaz, J; Davies, SM; Demmel, K; Cook, E; Salem, BM; Snyder, A; Juckett, M; Hartley, D. Engraft: A Collaborative Learning Health Network for Enhanced Transplant and Cellular Therapy Outcomes. Transplantation and Cellular Therapy. 2025; 31(3):123-134.

Davies, SM; Grimley, MS; Shrestha, A; Shova, A; Asnani, M; Kent, M; Sayani, F; Quinn, CT; Niss, O; Lutzko, CM; Witting, S; Latham, T; Bushman, FD; Malik, P. Gene Therapy with Reduced-Intensity Conditioning for Sickle Cell Disease. Transplantation and Cellular Therapy. 2025; 31(2):s2-s3.

Dávila Saldaña, BJ; Schultz, KR; Ramgopal, A; Boiko, JR; Beebe, K; Carpenter, PA; Chan, SS; Paczesny, S; Aguayo-Hiraldo, P; Cuvelier, GDE; Rotz, SJ; Duncan, CN; Williams, KM. Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part II. Organ Dysfunction and Immune Reconstitution Considerations for Children with Chronic Graft-versus-Host Disease after Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2025; 31(6):347.e1-347.e17.

Davis, K; Molloy, E; Marks, K; Breese, E; Taylor, JM; Broomall, E; Stalets, E. 667: SEVERE METHOTREXATE-INDUCED NEUROTOXICITY IN A HISPANIC ADOLESCENT GIRL WITH B-ALL. Critical Care Medicine. 2025; 53(1).

Dei-Adomakoh, YA; Segbefia, CI; Latham, TS; Lane, AC; Dzefi-Tettey, K; Amissah-Arthur, K; Corquaye, O; Korang, L; Mensah, E; Ekpale, P; Seedah, D; Stuber, SE; Smart, LR; Ware, RE. Hydroxyurea for Children and Adults with Hemoglobin SC Disease. NEJM Evid. 2025; 4(2):EVIDoa2400402.

Dela Cruz, FS; Fox, E; Dubois, SG; Friedman, GK; Croop, JM; Kim, A; Morgenstern, DA; Balis, FM; Macy, ME; Pressey, JG; He, CS; Aluri, J; Okpara, CE; Glade Bender, JL. A Phase 1/2 Study of Lenvatinib in Combination With Everolimus in Recurrent and Refractory Pediatric and Young Adult Solid Tumors. Pediatric Blood and Cancer. 2025; 72(7):e31692.

Desalvo, A; Ragon, B; Bhatt, N; Hamilton, BK; Borogovac, A; Horowitz, M; Khera, N; Juckett, M; Devine, S; Dandoy, C; Wall, S; Stewart, V; Heuer, M; Molfenter, T. Upstream integration of implementation planning in clinical trials through the blood and marrow transplant clinical trials network. Blood. 2025; 146(Supplement 1):7913-7913.

Dionisio, LM; Zheng, Y; Cancelas, JA. Redox Control in Platelet Activity and Therapy. Antioxidants. 2025; 14(11).

Djassemi, N; Kinoshita, H; Maghzian, N; Datar, A; Joy, E; Mccann, C; Shibli, A; Saldana, BD; Hoq, F; Hanley, PJ; Pulsipher, MA; Bollard, CM; Keller, MD. Outcome Analysis Post Virus-Specific T Cell Therapy for the Treatment of Adenoviremia in Immunocompromised Pediatric Patients. Transplantation and Cellular Therapy. 2025; 31(2):s221-s222.

Dombi, E; Gross, AM; Widemann, BC; Weiss, BD; Plotkin, SR; Ahlawat, S. Challenges in Assessing Response in Clinical Trials for Neurofibromatosis Type 1 Plexiform Neurofibromas. Journal of Clinical Oncology. 2025; 43(15):1843-1844.

Drozdov, D; Luo, X; Marsh, RA; Abraham, RS; Ebens, CL. Relevance of Recent Thymic Emigrants Following Allogeneic Hematopoietic Cell Transplantation for Pediatric Patients with Inborn Errors of Immunity. Transplantation and Cellular Therapy. 2025; 31(4):265.e1-265.e12.

Drucker, M; Pommert, L. When Treatment Becomes Personal: Cytarabine Pharmacogenomics Score Elucidates Outcome Disparities in Pediatric and Adolescent and Young Adult Acute Myeloid Leukemia. The Hematologist. 2025; 22(6).

Duan, H; Zhang, C; Zhang, Z; Wang, X; Zhang, J; Yang, L; He, F; Mao, L; Yang, L; Pan, Z; Pan, D; Yin, F; Xiao, W; Peng, J. Gene therapy with covalently closed-end AAV vector for spinal muscular atrophy. Molecular Therapy. 2025; 33(10):4848-4857.

Durkee-Shock, J; Cohen, A; Maghzian, N; Pezzella, G; Jensen-Wachspress, M; Hostal, A; Barton, K; Gangler, K; Dávila Saldaña, BJ; Chaimongkol, N; Gonzalez, C; Notarangelo, LD; Green, KY; Keller, MD. Reconstitution of Norovirus-Specific T-Cell Responses Following Hematopoietic Stem Cell Transplantation in Patients With Inborn Errors of Immunity and Chronic Norovirus Infection. Journal of Infectious Diseases. 2025; 231(3):773-783.

Dynan, L; Smith, RB; Quinn, CT. Inpatient and emergency healthcare utilization and payments for care of SCD: an analysis of all payers in Florida 2010-2019. Journal of Sickle Cell Disease. 2025; 2(1).

Eigenbrood, J; Wong, N; Mallory, P; Pereira, JS; Williams, D; Morris-Ii, DW; Beck, JA; Cronk, JC; Sayers, CM; Mendez, M; Leblanc, AK; Cotter, J; Kaplan, RN; Mceachron, TA. Spatial Profiling Identifies Regionally Distinct Microenvironments and Targetable Immunosuppressive Mechanisms in Pediatric Osteosarcoma Pulmonary Metastases. Cancer Research. 2025; 85(12):2320-2337.

El Kassar, N; Dezern, AE; Abkowitz, J; Artz, A; Beerman, I; Bolton, K; Brooks, MM; Borate, U; Ershler, WB; Ganz, T; White, KE; Zhang, D; Ferrucci, L; Kuchel, GA. A proposed path to explaining the unexplained anemia of aging. The journals of gerontology. Series A, Biological sciences and medical sciences. 2026; 81(1).

Elgammal, Y; Zhang, W; Kalfa, TA. Molecular surprises in evaluations of red cell disorders. Hematology. American Society of Hematology. Education Program. 2025; 2025(1):370-376.

Elgammal, Y; Ntoumaziou, A; Romano, L; Blanc, L; Seu, K; Salomonis, N; Kalfa, T. Characterization of the human erythromyeloblastic islands (EMBIs) Blood. 2025; 146(Supplement 1):182-182.

Elgammal, Y; Hamdan, L; Risinger, M; Kostantinidis, D; Seu, K; Mcelhinney, K; Niss, O; Nemeth, E; Quinn, C; Ware, R; Kalfa, T. Biomarkers of ineffective erythropoiesis in patients with sickle cell anemia, at baseline and while treated with hydroxyurea, in comparison to patients with other iron-loading red cell disorders. Blood. 2025; 146(Supplement 1):4686.

Eng, W; Iacobas, I; Perkins, J; Zampino, G; Leoni, C; Buonuomo, PS; Simonetti, A; Goel, H; Briones, M; Huang, M; Goldmacher, G; Liaw, D; Hammill, A. Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA-related overgrowth spectrum or Proteus syndrome. Orphanet Journal of Rare Diseases. 2025; 20(1):375.

Engel, ER; Luchtman-Jones, L. Comment on: "Comment on: Bivalirudin During Thrombolysis With Catheter-Directed tPA in a Heparin-Refractory Patient: A Case Report": The Promise of Dilute Thrombin Time and Drug-Calibrated Assays for Improved Bivalirudin Monitoring. Pediatric Blood and Cancer. 2025; 72(1):e31418.

Fangusaro, J; Onar-Thomas, A; Young Poussaint, T; Lensing, S; Ligon, AH; Lindeman, N; Banerjee, A; Kilburn, LB; Lenzen, A; Pillay-Smiley, N; Jones, DTW; Stewart, CF; Fouladi, M; Dunkel, IJ. A phase 2 PBTC study of selumetinib for recurrent/progressive pediatric low-grade glioma: Strata 2, 5, and 6 with long-term outcomes on strata 1, 3, and 4. Neuro-Oncology. 2025; 27(9):2415-2428.

Fargo, J; Alleyne, M; Amankwah, E; Acharya, S; Wilson, H; Male, C; Rajpurkar, M; Tarango, C; Sidonio, Jr., R; Schulman, S; Goldenberg, N. Clinically relevant bleeding and heavy menstrual bleeding among patients <21 years old with provoked VTE: Findings from the multinational kids-DOTT trial. Blood. 2025; 146(Supplement 1):316-316.

Fathi Kazerooni, A; Khalili, N; Liu, X; Haldar, D; Jiang, Z; Zapaishchykova, A; Pavaine, J; Shah, LM; Jones, BV; Sheth, N; Resnick, A; Bakas, S; Vossough, A; Linguraru, MG. BraTS-PEDs: Results of the Multi-Consortium International Pediatric Brain Tumor Segmentation Challenge 2023. MELBA journal. 2025; 3(June 2025):72-87.

Faulk, KE; Kairalla, JA; Hibbitts, E; Long-Boyle, J; Devidas, M; August, A; Gore, L; Raetz, E; Hunger, SP; Loh, ML; Teachey, DT; Brown, P; Breese, EH; Kotecha, RS; Guest, E. Age-based pegaspargase dosing is safe and achieves therapeutic levels in infants with ALL: report from COG AALL15P1. Blood advances. 2026; 10(1):70-74.

Fernandez, K; Hoetink, A; Konrad-Martin, D; Berndtson, D; Clark, K; Dreisbach, L; Geller, JI; Goffi-Gomez, MV; Grosnik, A; Jamis, C; Sanchez, VA; Van Den Heuvel-Eibrink, MM; Brewer, CC; Poling, GL. Roadmap to a Global Template for Implementation of Ototoxicity Management for Cancer Treatment. Ear and Hearing. 2025; 46(2):286-297.

Fidler, AL; O'connor, G; Beebe, DW; Wang, YM; Crosby, LE; Dandoy, CE. How to Improve the Sleep of Hospitalized Pediatric Patients: Family and Staff Focus Groups. Transplantation and Cellular Therapy. 2025; 31(8):586.e1-586.e11.

Fisher, J; Stepanchick, E; Wilson, A; Kida, J; Badar, T; Lasho, T; Kusne, Y; Patnaik, M; Chlon, T. The somatic hotspot mutation of DDX41 (p.R525H) elicits dominant-negative effects upon non-truncating germline variants, explaining similar disease risk as truncating variants. Blood. 2025; 146(Supplement 1):3221-3221.

Fisher, AA; Gonzalez, LS; Cappel, ZR; Grover, KE; Waclaw, RR; Robinson, JE. Dopaminergic encoding of future defensive actions in the mouse nucleus accumbens. PNAS Nexus. 2025; 4(5):pgaf128.

Fragneau, R; Fraitag, S; Kemps, PG; Hélias-Rodzewicz, Z; Roy, S; Bonsang, B; Bartlett, AL; Dhar, S; Jankofsky, M; Zlocha, J; Donadieu, J; Borkhardt, A; Picarsic, JL; Emile, J-F. NTRK1-rearranged histiocytosis: clinicopathologic and molecular features. Blood advances. 2025; 9(14):3617-3628.

Freyer, DR; Ohlsen, TJD; Don, D; Orgel, E; Hayashi, RJ; Lieu, JE; Foster, JH; Sitton, MS; Geller, JI; Choo, DI; Grunstein, E; O'neill, AF; Rahbar, R; Anderson, JJ. Feasibility and Safety of Intratympanic Administration of Sustained-Exposure Dexamethasone Thermosensitive Gel (OTO-104) for Prevention of Cisplatin-Induced Hearing Loss in Children: A Multisite Phase 2 Randomized Clinical Trial. Pediatric Blood and Cancer. 2025; 72(6):e31680.

Frigault, MJ; Maziarz, RT; Park, JH; Lazaryan, A; Shah, NN; Svoboda, J; Lekakis, L; Reshef, R; Phillips, CL; Burke, L; Lei, J; Pratta, M; Morariu-Zamfir, R; Dipersio, JF. Itacitinib for the prevention of IEC therapy-associated CRS: results from the 2-part phase 2 INCB 39110-211 study. Blood. 2025; 146(4):422-436.

Galletta, TJ; Benoit, SW; Markham, J; Pillay-Smiley, N; Queen, K; Graham, RT. Elevated Bromide Levels Due to Tazemetostat Therapy Treated With Salt and Water Supplementation in Two Children With Atypical Teratoid Rhabdoid Tumor. Pediatric Blood and Cancer. 2025; 72(8):e31803.

Garrett, MC; Carnwath, T; Albano, R; Zhuang, Y; Behrmann, CA; Pemberton, M; Barakat, F; Lober, R; Hoeprich, M; Paravati, A; Perentesis, J; Nasser, R; Medvedovic, M; Plas, DR. CPI203, a BET inhibitor, down-regulates a consistent set of DNA synthesis genes across a wide array of glioblastoma lines. PLoS ONE. 2025; 20(5):e0306846.

Geller, JI; Renfro, LA; Grundy, PE; Perlman, EJ; Kalapurakal, JA; Ehrlich, PF; Biegel, J; Huff, V; Warwick, AB; Paulino, A; Ward, DA; Anderson, JR; Fernandez, CV; Dome, JS. Rhabdoid Tumor of the Kidney and Soft Tissues: Results from National Wilms Tumor Study-5 and Children's Oncology Group Study AREN0321. Pediatric Blood and Cancer. 2025; 72(3):e31490.

Ghalehsari, N; Pandey, M; Auletta, JJ; Beaver, E; Davies, SM; Espinoza-Gutarra, MR; Fraint, E; Holter-Chakrabarty, J; Howard, D; Knutson, J; Ramos, KN; Shah, R; Hall, AG; Gomez-Arteaga, A. Physician Advocacy for Hematopoietic Cell Transplantation and Cell Therapy: Overcoming Challenges to Reduce Disparities and Improve Outcomes for Patients. Transplantation and Cellular Therapy. 2026; 32(1):12.e1-12.e4.

Ghosh, A; Li, H; Towbin, A; Turpin, B; Trout, A. T2-weighted MRI radiomics for the prediction of pediatric and young adult rhabdomyosarcoma alveolar subtype and distant metastasis: a pilot study. Pediatric Radiology. 2025; 55(6):1149-1161.

Gilene, S; D'aquila, K; Cooper, B; Szabo, S; Pressey, JG. Dramatic multifocal osteosarcoma treatment response in the setting of POT1 tumor predisposition syndrome. Cancer Genetics. 2025; 298-299:39-43.

Gilene, S; Haacker, L; Rutan, H; Pressey, JG. The Threat of Medical Misinformation: A Case of Ivermectin Toxicity in a Pediatric Oncology Patient. Pediatric Blood and Cancer. 2025; 72(9):e31876.

Gilene, S; Knapke, S; Leino, D; Roy, S; Raskin, S. A novel POT1-TPD presentation: A germline pathogenic POT1 variant discovered in a patient with newly diagnosed posterior fossa ependymoma. Cancer Genetics. 2025; 292-293:38-43.

Gilliam, CA; Deblasio, D; Poynter, SE; Vukovic, AA; Kinnear, B. Reprioritizing and embracing change: Implications of the ACGME revised requirements on pediatric medical education and hospital medicine. Journal of Hospital Medicine. 2025; 20(9):1009-1011.

Ginocchio, MP; Gutarra, ME; Ramos, KN; Shah, R; Pandey, M; Ghalehsari, N; Davies, SM; Auletta, JJ; Hall, AG; Arteaga, AG. Understanding Diversity: An ASTCT-NMDP Access Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Nonphysician Workforce. Transplantation and Cellular Therapy. 2025; 31(2):s343-s344.

Ginocchio, MP; Ramos, KN; Gutarra, ME; Ghalehsari, N; Pandey, M; Shah, R; Davies, SM; Auletta, JJ; Arteaga, AG; Hall, AG. Physician Workforce Diversity in the Hematopoietic Cell Transplant and Cellular Therapy Ecosystem: An ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy. 2025; 31(2):s361.

Girgis, MK; Lopachin, TR; Hallett, TC; Briones, MA; Desai, NJ; Mcelhinney, KE; Ware, RE; Yee, MEM. Prolonged, Unintentional Overdose of Hydroxyurea in a Child With Sickle Cell Anemia. Pediatric Blood and Cancer. 2025; e70076.

Goda, C; Kulkarni, R; Bustos, Y; Li, W; Rudich, A; Balcioglu, O; Chidester, S; Urs, AP; Karunasiri, M; Al-Marrawi, Y; Viny, AD; Miles, LA; Miller, KE; Dorrance, AM. Cellular taxonomy of the preleukemic bone marrow niche of acute myeloid leukemia. Leukemia. 2025; 39(1):51-63.

Goldenberg, NA; Schulman, S; Kittelson, JM; Abshire, TC; Casella, JF; Dale, R; Halperin, JL; Hanson, J; Kessler, CM; Manco-Johnson, MJ; Mcdevitt, L; Sidonio, RF; Spyropoulos, AC; Steg, PG; Bonaca, MP. Duration of anticoagulation for venous thromboembolism in pediatric patients: Evaluation of the Duration of Therapy for Thrombosis in Children (Kids-DOTT) trial outcomes at 2 years. Journal of Thrombosis and Haemostasis. 2025; 23(2):651-656.

Gonzalez, LS; Fisher, AA; Grover, KE; Robinson, JE. Examining the role of the photopigment melanopsin in the striatal dopamine response to light. Frontiers in Systems Neuroscience. 2025; 19:1568878.

Gopu-Gilboy, A; Sheak, JR; Monangi, N; Damianos, A; Pommert, L. Shining a TORCH on a Case of Blueberry Muffin Rash in a Newborn Infant. NeoReviews. 2025; 26(3):e191-e196.

Gower, WA; Tamae-Kakazu, M; Shanthikumar, S; Srinivasan, S; Reardon, EE; Barochia, AV; Charbek, E; Calvo, C; Cheng, PC; Das, S; Sheshadri, A; Towe, CT; Goldfarb, SB; Iyer, NP. Pulmonary function testing in pediatric allogeneic stem cell transplant recipients to monitor for Bronchiolitis obliterans syndrome: a systematic review. BMC Pediatrics. 2025; 25(1):250.

Gower, M; Li, X; Aguilar-Navarro, AG; Lin, B; Fernandez, M; Edun, G; Nader, M; Rondeau, V; Arruda, A; Tierens, A; Jones, CL; Dolgalev, I; Jahangiri, S; Tikhonova, AN. An inflammatory state defines a high-risk T-lineage acute lymphoblastic leukemia subgroup. Science Translational Medicine. 2025; 17(779):eadr2012.

Graff, Z; Pommert, L. DARA to Believe: Anti-CD38 Antibody Improves Outcomes in Relapsed/Refractory Pediatric T-Cell Lymphoblastic Leukemia and Lymphoma. The Hematologist. 2025; 22(3).

Grassia, KL; Diseroad, E; Jodele, S; Dandoy, CE; Towe, C; Davies, SM; Sabulski, A. Managing Diffuse Alveolar Hemorrhage in Pediatric HSCT with Inhaled and Intrabronchial Therapy: A Case Series of Targeted Hemostatic Intervention. Transplantation and Cellular Therapy. 2025; 31(2):s153.

Grimley, M; Davies, SM; Shrestha, A; Shova, A; Asnani, M; Kent, M; Sayani, F; Quinn, CT; Niss, O; Lutzko, C; Witting, S; Latham, T; Bushman, FD; Malik, P. Lentiviral gene therapy with reduced-intensity conditioning for sickle cell disease: a phase 1/2 trial. Nature Medicine. 2025; 31(7):2204-2212.

Gross, AM; Reid, OH; Baldwin, LA; Cannon, A; Choo-Wosoba, H; Steinberg, SM; Lobbous, M; Wolters, PL; Pichard, DC; Tibery, CM; Dombi, E; Derdak, J; Widemann, BC; Korf, BR. Treatment of Cutaneous Neurofibromas in Neurofibromatosis Type 1 With MEK Inhibitor Selumetinib: A Nonrandomized Clinical Trial. JAMA dermatology. 2025; 161(5):533-537.

Gross, AM; O'sullivan Coyne, G; Dombi, E; Tibery, C; Herrick, WG; Martin, S; Angus, SP; Shern, JF; Rhodes, SD; Foster, JC; Srivastava, AK; Doroshow, JH; Chen, AP; Widemann, BC. Selumetinib in adults with NF1 and inoperable plexiform neurofibroma: a phase 2 trial. Nature Medicine. 2025; 31(1):105-115.

Grupp, S; Grimley, M; Driscoll, T; Mahadeo, K; Leonard, A; Wang, Y; Phillips, H; Justus, D; Lehmann, L; Esrick, E; Tisdale, J; Sharma, A; Crees, Z; Manis, J. Improved hematopoietic stem cell mobilization for gene therapy using single agent motixafortide in sickle cell disease. Blood. 2025; 146(Supplement 1):2542-2542.

Gwarzo, I; Coleman, KD; Mckinley, K; Ellison, AM; Alpern, ER; Corboy, J; Hariharan, S; Topoz, I; Wurtz, M; Nielsen, B; King, AA; Baumann, A; Frankenberger, W; Brousseau, DC. Opioid Timeliness in the Emergency Department and Hospitalizations for Acute Sickle Cell Pain. JAMA pediatrics. 2025; 179(11):1194-1202.

Haacker, L; Littner, L; Martin, M; Brokamp, C; Beck, AF; Luchtman-Jones, L. Anemia in Young Children and the Association With Socioeconomic Deprivation Indices. Pediatric Blood and Cancer. 2025; 72(7):e31663.

Haacker, L; Littner, L; Martin, M; Brokamp, C; Beck, AF; Luchtman-Jones, L. Reply to: Comment on Anemia in Young Children and the Association With Socioeconomic Deprivation Indices. Pediatric Blood and Cancer. 2025; 72(7):e31743.

Hahn, TE; Zhao, Q; Miller, EG; Elder, P; Langenberg, L; Davies, SM; Bejanyan, N; Vasu, S. Incidence of Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Is Not Lowered By Reduction of Acute GvHD (aGvHD) in Patients Receiving Post-Transplant Cyclophosphamide (PTCy) GvHD Prophylaxis: A Report from the MIDAS (Microangiopathy, Endothelial Damage in Adults undergoing Stem cell transplantation) Consortium. Transplantation and Cellular Therapy. 2025; 31(2):s282.

Hall, AD; Hendricks, HA; Bowers, KA; Geller, JI; Bondoc, AJ; Tiao, GM; Taylor, AE; Otto, WR; Paulsen, GC; Danziger-Isakov, LA. Impact of Hepatoblastoma on Infectious Complications Following Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29(1):e70035.

Hamarsha, Q; Choaib, A; Azzam, M; Kawtharany, H; Khawandi, J; Alkhader, A; Nazzal, J; Alkasrawi, H; Khanfar, O; Betensky, M; Wilson, H; Woods, G; Velez-Yanguas, M; Mustafa, R. Title: Role of primary VTE prophylaxis in pediatric leukemia, lymphoma, and solid tumors: A systematic review and meta-analysis. Blood. 2025; 146(Supplement 1):3139-3139.

Hamdan, L; Elgammal, Y; Husami, A; Meznarich, J; Fasipe, F; Chonat, S; Mclemore, M; Schwartz, J; Sahib, S; Mccavit, T; Zhang, W; Lorsbach, R; Niss, O; Kalfa, T. Congenital dyserythropoietic anemia type I: Updated report from the congenital dyserythropoietic anemia registry of North America. Blood. 2025; 146(Supplement 1):4685-4685.

Hamdan, L; Elgammal, Y; Shova, A; Aygun, B; Quinn, C; Niss, O; Kalfa, T. Biomarkers of ineffective erythropoiesis in patients with transfusion- dependent thalassemia. Blood. 2025; 146(Supplement 1):4684-4684.

Hanenberg, H; Zhang, F; Malev, N; Wiek, C; Klamer, BG; Nassar, N; Hesselbrock, T; Hanenberg, JH; Aeilts, AM; Hentschel, J; Hauke, J; Niederacher, D; Toland, AE; Andreassen, PR. Reclassification of ATM Missense Variants of Uncertain Significance by Integrating Results from Systematic Functional Assays into an ACMG Points-Based Framework. Clinical Cancer Research. 2025; 31(12):2426-2440.

Haney, M; Devine, KJ; Xavier, AC; Ford, JB; Audino, AN; Villagomez, L; Kebede, A; Rubinstein, JD. Posttransplant EBV-Positive Smooth Muscle Tumors in Children, Adolescents, and Young Adults: A Multi-Institution Experience. Pediatric Blood and Cancer. 2025; 72(6):e31678.

Haney, M; Ashraf, A; Lake, KE; Strecker, L; Myers, KC; Towe, C; Walkup, L; Woods, J; Edwards, SL; Cooper, R; Goldfarb, SB; Davies, SM; Koo, J; Groups, T. Community respiratory viruses are generally welltolerated in hematopoietic stem cell transplant recipients: a brief report from the TRANSPIRE study. Haematologica. 2025; 110(8):1882-1886.

Hassanzadeh, S; Zeches, BA; Husami, A; Kalfa, TA; Knupp, CL; Richardson, MD. 467 Hereditary predisposition syndrome for myelodysplastic syndrome with SF3B1 mutation; a case report. American Journal of Clinical Pathology. 2025; 164(Supplement_1):aqaf121.272.

Hau, DK; Ruselu, G; Peck, RN; Downs, JA; Manyangu, GJ; Masoza, TS; Kisigo, GA; Smart, LR. Reducing Harm in Cultural Transition: Repurposing the 5 Stages of Grief Model for Global Health Experiences. Journal of Graduate Medical Education. 2025; 17(6):689-693.

Hau, DK; Fadhil, S; Lee, MH; Desderius, B; Willkens, M; Kalluvya, SE; Tebuka, E; Smart, LR; Peck, RN. Causes and Consequences of Persistent Anemia after 6 Months of Antiretroviral Therapy in Tanzania: An Observational Comparative Cohort Study. American Journal of Tropical Medicine and Hygiene. 2025; 112(1):234-241.

Hildenbrand, AK; Mara, CA; Murphy, B; Hood, AM; Johnson, Y; Shook, LM; Real, FJ; Nwankwo, C; Hackworth, R; Badawy, SM; Saving, KL; Treadwell, M; Quinn, CT; Crosby, LE. Engaging Parents of Children With Sickle Cell Disease in Shared Decision-Making for Hydroxyurea: The ENGAGE-HU Study. Pediatric Blood and Cancer. 2025; 72(5):e31639.

Hoeksema, P; Hayatghaibi, S; Sharp, SE; Li, Y; Anton, CG; Norris, RE; Trout, AT. Discrepancies between primary and secondary interpretations of pediatric nuclear medicine imaging examinations. Pediatric Radiology. 2025.

Hoyt, SB; Finocchio, CJ; Croll, E; Tawa, GJ; Zhang, M; Wang, J; Li, H; Ma, L; Li, K; Zhang, X; Culver-Cochran, AE; Rosenbaum, JS; Starczynowski, DT; Thomas, CJ. IRAK1/4/pan-FLT3 Kinase Inhibitors with Reduced hERG Block as Treatments for Acute Myeloid Leukemia. ACS Medicinal Chemistry Letters. 2025; 16(5):887-895.

Hsu, AY; Huang, Q; Pi, X; Fu, J; Raghunathan, K; Ghimire, L; Balasubramanian, A; Xie, X; Yu, H; Loison, F; Thiagarajah, JR; Wu, H; Feng, S; Luo, HR. Neutrophil-derived vesicles control complement activation to facilitate inflammation resolution. Cell. 2025; 188(6):1623-1641.e26.

Huber, J; Auletta, JJ; Cook, E; Culbertson, C; Diaz, J; Fitch, T; Flesch, L; French, K; Jaglowski, S; Jodele, S; Snyder, AJ; Hartley, D; Dandoy, CE; Liang, WH. Establishing the Engraft Multi-Center Tri-Use Registry. Transplantation and Cellular Therapy. 2025; 31(2):s529-s530.

Hudda, Z; Webster, A; Anderson, E; Badia, P; Bagatell, R; Bhar, S; Bidgoli, A; Boyd, K; Chaudhury, S; Cisneros, GS; Weiss, BD; Yazdani, S; Zheng, D; Dandoy, CE. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2025.

Hudda, Z; Schoettler, ML; Rotz, SJ; Kapadia, M; Lehmann, LE; Freedman, JL; Pater, L; Weiss, B; Badia, P; Davies, SM; Mormann, M; Desai, A; Webster, A; Dandoy, CE. Acute Toxicities and Early Outcomes of Tandem Autologous Stem Cell Transplantation in Pediatric High-Risk Neuroblastoma: A Multicenter Study. Transplantation and Cellular Therapy. 2025; 31(2):s93-s94.

Hudda, Z; Davies, SM; Lane, A; Schiff, DE; Anderson, EJ; Mehta, PA; Myers, KC; Gloude, NJ. Abatacept Prevents Severe Acute Graft-Versus-Host Disease Without Increasing Graft Failure Risk in Pediatric Bone Marrow Failure Syndromes. Pediatric Blood and Cancer. 2025; 72(12):e32085.

Hudda, Z; Flannery, A; Dillhoff, P; Webster, K; Jacobs, J; Strong, S; Detzel, J; Davies, SM; Khandelwal, P. Chronic Graft-Versus-Host Disease Adversely Impacts School Performance in Children and Young Adults. Transplantation and Cellular Therapy. 2025; 31(2):99.e1-99.e11.

Hudda, Z; Lawhorn, E; Mani, B; Badia, P; Frias, O; Myers, KC; Howell, JC; Burns, K. Longitudinal Outcomes of Fertility Potential in Female Pediatric and Young Adult Allogeneic Hematopoietic Stem Cell Transplant Survivors. Transplantation and Cellular Therapy. 2025; 31(2):s98.

Hussain, M; Nagarsheth, N; Jones, J; Bleesing, J; Chandra, S; Marsh, R; Dansereau, C; O'donnell, M; Silva, O; Kerwin, B; De Ravin, SS; Prockop, S; Williams, D; Pai, S-Y. A Novel Dominant Negative Variant in IL2RG Gene that Failed to Be Corrected by Lentiviral Gene Therapy. Journal of Human Immunity. 2025; 1(CIS2025).

Hyeong, J; Koo, J; Rim, M; Wi, Y; Ko, H; Yu, D; Kim, S; Kim, N; Yoo, MJ; Jeong, K-U. Stretchable Heat Transfer Eco-Materials: Mesogen Grafted NR-Based Nanocomposites with High Thermal Conductivity and Low Dielectric Constant. Small. 2025; 21(2):e2406066.

Ibrahimova, A; Bidgoli, A; Ashraf, A; Krogman, A; Klink, G; Teusink-Cross, A; Schoettler, ML; Davies, SM; Khandelwal, P. Real world experience using belumosudil for treatment of chronic graft versus host disease in children and young adults. Bone Marrow Transplantation. 2026.

Ibrahimova, A; Khoury, R; Jodele, S; Grimley, M; Davies, SM; Khandelwal, P. Abatacept for acute graft versus host disease prophylaxis in children with sickle cell disease patients undergoing HLA identical sibling hematopoietic stem cell transplantation. Bone Marrow Transplantation. 2025; 60(8):1102-1107.

Ibrahimova, A; Luebbering, N; Langenberg, L; Abdullah, S; Strecker, L; Lake, KE; Lane, A; Webster, A; Myers, KC; Jodele, S; Davies, SM. Kinetics of DNases after hematopoietic stem cell transplant. Blood Vessels, Thrombosis & Hemostasis. 2025; 2(2):100055.

Ibrahimova, A; Ashraf, A; Klink, G; Teusink-Cross, A; Davies, SM; Khandelwal, P. Single Center Experience of Belumosudil in Children < 12 Years, Adolescents and Young Adults. Transplantation and Cellular Therapy. 2025; 31(2):s305-s306.

Ishikawa, C; Barreyro, L; Sampson, AM; Hueneman, KM; Choi, K; Philbrook, SY; Choi, I; Bolanos, LC; Wunderlich, M; Volk, AG; Watowich, SS; Greis, KD; Starczynowski, DT. Ubiquitin-conjugating enzyme UBE2N modulates proteostasis in immunoproteasome-positive acute myeloid leukemia. Journal of Clinical Investigation. 2025; 135(10).

Ismail, M; Um, H; Pytel, N; Salloum, R; Rebsamen, S; De Blank, P; Tiwari, P. IMG-71. Stability of radiomics in pediatric medulloblastoma: a multi-institutional preliminary analysis. Neuro-Oncology. 2025; 27(Supplement_5):v289-v290.

Ismail, M; Um, H; Pineda, G; Salloum, R; Hollnagel, F; Ahmed, R; De Blank, P; Tiwari, P. Radiomic-based prognostic score for survival risk-stratification in pediatric medulloblastoma tumors: A multi-institutional study. Neuro-Oncology Advances. 2025; 7(1):vdaf107.

Iwata, W; Adachi, Y; West, JJ; Ewald, AJ; Zheng, Y; Wood, LD; Anders, RA; Sesaki, H; Iijima, M. Context-dependent inhibitory roles of RhoA in 3D invasive cell migration within the extracellular matrix. Cell reports. 2025; 44(12):116649.

Iyer, VN; Vethanayagam, D; Al-Samkari, H; Beslow, LA; Chakinala, M; Decker, JE; Faughnan, ME; Galiatsatos, P; Gane, S; Geisthoff, U; White, AJ; Zhou, J; Friday, C; Clancy, M. Letter to the editor. European Archives of Oto-Rhino-Laryngology. 2025.

Jan, S; Steinway, C; Belton, T; Shults, J; Bennett, L; Teng, O; Griffis, H; Aygun, B; Appiah-Kubi, A; Apollonsky, N; Andemariam, B; Mulchan, SS; Rubin, D; Smith-Whitley, K. Community Health Worker and Mobile Health Interventions for Quality of Life Among Young Adults With Sickle Cell Disease: A Randomized Clinical Trial. JAMA Network Open. 2025; 8(11):e2543571.

Jodele, S. Targeting the lectin pathway in TA-TMA. Blood advances. 2026; 10(1):181-182.

Jodele, S; Gavriilaki, E. Translating biomarker insights into practice: a path forward in TA-TMA management. Frontiers in Medicine. 2025; 12:1550365.

John, S; Curran, KJ; Hall, EM; Keating, AK; Baumeister, SHC; Nikiforow, S; Driscoll, T; Moskop, A; Mcnerney, KO; Phillips, CL; Ramos, R; Krueger, J; Guest, E; Grupp, SA. Real-world data for tisagenlecleucel in patients with R/R B-ALL: subgroup analyses from the CIBMTR registry. Blood advances. 2025; 9(20):5249-5262.

Johnstone, ME; Leck, AL; Lange, TE; Wilcher, KE; Shephard, MS; Paranjpe, A; Schutte, S; Wells, SI; Kappes, F; Salomonis, N; Privette Vinnedge, LM. DEK promotes mammary hyperplasia and is associated with H3K27me3 epigenetic modifications. Life Science Alliance. 2025; 8(9).

Jones, L; Khadaroo, A; Tiwari, R; Choi, K; Adam, M; Wunderlich, M; Stillwell, C; Sexton, C; Seibel, W; Tawa, G; Hoyt, S; Thomas, C; Starczynowski, D. FLT3-F691L confers kinase-independent resistance via Grb2-dependent MAPK signaling in AML. Blood. 2025; 146(Supplement 1):5049-5049.

Josephson, M; Boas, H; Freedman, J; Young, LR; Goldfarb, SB; Robinson, PD; Towe, C; Gaffin, JM; Wong, W; Koo, J; Lane, A; Davies, SM; Mc Donough, J; Allen, JL. Intrabreath Oscillometry (IBO) vs. Spectral Oscillometry (SO) in Detecting Respiratory Disease in Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT) American Journal of Respiratory and Critical Care Medicine. 2025; 211(Supplement_1):a5118-a5118.

Kalfa, TA. The diagnosis and treatment of red cell membrane disorders: algorithm for the general hematologist. Clinical Advances in Hematology and Oncology. 2025; 23(9):534-538.

Kawtharany, H; Azzam, M; Alkhader, A; Betensky, M; Hamarsha, Q; Abou Zeid, HK; Mansour, R; Tabak, C; Patel, P; Baghdadi, SL; Woods, G; Zia, A; Monagle, P; Mustafa, RA. Efficacy and safety of thrombolysis for pediatric venous thromboembolism: a systematic review and meta-analysis. Blood advances. 2025; 9(21):5512-5527.

Kelleher, JA; Bernstein, JL; Crisler, KM; Herriott, JK; Klages, KL; Norris, RE; Strenk, ML; Bills, SE; Mcgrady, ME. Patient-Level Barriers and Facilitators to Inpatient Physical Therapy in Adolescents and Young Adults With a Hematological Malignancy: A Qualitative Study. Pediatric Blood and Cancer. 2026; e70129.

Khanal, N; Summey, V; Bailey, J; Duan, X; Zheng, Y; Zhu, L; Stringer, K; Rao, M; Banerjee, RK. Development of Mouse-Tumor Model Using Prostate Cancer (PC3) Cell Line for High-Intensity Focused Ultrasound (HIFU) Ablation. Prostate Cancer. 2025; 2025:5678314.

Khandelwal, P; Fish, JD; Gorfinkel, L; Guilcher, GMT; Howell, J; Nishitani, M; Nuechterlein, B; Obeng, E; Shah, AJ; Cuvelier, GDE; Rotz, S; Williams, KM; Duncan, CN. Pediatric Transplant and Cellular Therapy Consortium RESILIENT Conference on Pediatric Chronic Graft-versus-Host Disease Survivorship after Hematopoietic Cell Transplantation: Part III. Long-Term Impact of Chronic Graft-versus-Host Disease on Endocrinologic, Cardiovascular, and Metabolic Outcomes in Survivors of Pediatric Hematopoietic Cell Transplantation. Transplantation and Cellular Therapy. 2025; 31(5):297.e1-297.e15.

Khandelwal, P; Ibrahimova, A; Lane, A; Grimley, M; Davies, SM; Jodele, S. Abatacept improves posttransplant survival and reduces endothelial injury syndromes in β-thalassemia major. Blood advances. 2025; 9(24):6370-6379.

Khot, B; Suriyaarachchi, H; Majumder, T; Nathan, A; Lu, QR; Liu, G. miR-219a-Robo1 axis acts as a conserved switch for slit-mediated commissural axon guidance. iScience. 2025; 28(12):114242.

Khoury, R; Jordan, M; Bleesing, J; Kumar, A; Saldana, BD; Verkamp, B; Davies, S; Marsh, R; Chandra, S. Addition of Thiotepa to Alemtuzumab, Fludarabine, and Melphalan Reduced-Intensity Conditioning Reduces Secondary Graft Failure in Allogeneic HSCT for Inborn Errors of Immunity. Journal of Human Immunity. 2025; 1(CIS2025).

Kiang, KM; Wong, YKH; Sengupta, S; Roussel, MF; Lu, QR. Developmental Origins and Oncogenesis in Medulloblastoma. Annual Review of Neuroscience. 2025; 48(1):85-102.

Kida, J; Fricker, M; Stepanchick, E; Kusne, Y; Badar, T; Lasho, T; Patnaik, M; Chlon, T. The somatic DDX41 hot spot mutation (p.R525H) causes skewed differentiation into plasmacytoid dendritic cells in human iPSC and leukemia models. Blood. 2025; 146(Supplement 1):678-678.

Kida, J; Chlon, TM. Germline DDX41 mutations in myeloid neoplasms: the current clinical and molecular understanding. Current Opinion in Hematology. 2025; 32(2):67-76.

Kim, A; Ballman, KV; Wolters, PL; Heise, RS; Shern, JF; Sundby, RT; Lindenberg, L; Lee, M-J; Rastogi, S; Sato, N; Gross, AM; Reinke, D; Cichowski, K; Widemann, BC. SARC031: A Phase 2 Trial of Selumetinib and Sirolimus for Patients with Unresectable or Metastatic Malignant Peripheral Nerve Sheath Tumors (MPNST). Clinical Cancer Research. 2026.

Kirstein, A; Ionascu, D; Lamba, MAS; Ruffolo, BM; Crail, KJ; Mascia, AE; Sertorio, MG; Hinrichs, BH; Zender, C; Lehn, MA; Wise-Draper, TM; Perentesis, JP; Zheng, Y; Wells, SI. In vitro determination of patient-specific variation challenges the universal RBE gold standard for proton radiation therapy. Clinical and Translational Radiation Oncology. 2026; 56:101046.

Klages, KL; Herriott, JK; Breen, G; Norris, RE; Beal, SJ; Sorge, CE; Pai, ALH; Mcgrady, ME. Pain, Internalizing Symptoms, Posttraumatic Stress, and Alcohol Use Among Young Adult Survivors of Cancer. Pediatric Blood and Cancer. 2026; e70154.

Klages, K; Nelson, C; Herriott, J; Norris, R; Kashikar-Zuck, S; Pai, A. 396 Pain Experiences Among Children Receiving Treatment for Acute Lymphoblastic Leukemia. Journal of Pain. 2025; 29:105194.

Klages, KL; Gibson, CA; Barnett, KA; Schwartz, LE; Hicks, CA; Norris, RE; Kashikar-Zuck, S; Pai, ALH. Systematic Review of Pain Assessment Measures Used in Pediatric Acute Lymphoblastic Leukemia. Psycho-Oncology. 2025; 34(1):e70063.

Klaver, YLB; Hoogeman, MS; Lu, QR; Bradley, JD; Choi, JI; Ferris, MJ; Grau, C; Guha, C; Lin, H; Lin, L; Zhou, S; Amos, RA; Hawkins, M; Simone, CB. Requirements and Study Design for the Next Proton FLASH Clinical Trials: an International Multidisciplinary Delphi Consensus. International Journal of Radiation Oncology Biology Physics. 2025; 123(1):296-305.

Koch, A; Childress, A; Vallee, E; Steller, A; Raskin, S. The Current Landscape of Molecular Pathology for the Diagnosis and Treatment of Pediatric Medulloblastoma. Journal of Molecular Pathology. 2025; 6(2):11.

Koch, A; Derinkuyu, B; Webster, A; Mochizuki, A; Pillay-Smiley, N; Graham, RT. BIOM-88. LEPTOMENINGEAL METASTASIS IN THE INTERNAL AUDITORY CANAL AS A PREDICTOR OF OUTCOMES FOR CHILDREN WITH CENTRAL NERVOUS SYSTEM TUMORS. Neuro-Oncology. 2025; 27(Supplement_5):v45-v45.

Konduri, M; Boe, D; Yazigi, N; Khan, K; Ward, BR; Saldana, BD; Cavener, D; Kallakury, B; Kroemer, A; Matsumoto, C; Fishbein, T; Ekong, UD. Wolcott-Rallison syndrome - crosstalk between PERK- EIF2A and type II interferon signaling. European Journal of Medical Genetics. 2025; 76:105022.

Koo, J; Webster, A; Lake, KE; Luebbering, N; Dandoy, C; Jodele, S; Ryan, TD; Davies, SM; Sabulski, A. Proteomic analysis of pericardial effusions in hematopoietic stem cell transplant recipients. Haematologica. 2025.

Koo, J; Webster, A; Dandoy, CE; Jodele, S; Davies, SM; Sabulski, A. The Tell-Tale Heart: A Cytokine Storm Story of Pericardial Effusions after HSCT. Transplantation and Cellular Therapy. 2025; 31(2):s137.

Koo, J; Cooper, R; Edwards, SL; Lane, A; Loveless, SK; Strecker, L; Lake, KE; Myers, KC; Towe, C; Patti, J; Li, M; Goldfarb, SB; Woods, JC; Davies, SM. High Prevalence of Abnormal Baseline Lung Function in Pediatric and Young Adult Hematopoietic Stem Cell Transplant Recipients: A Report from the TRANSPIRE Study. Pediatric Blood and Cancer. 2025; 72(10):e31916.

Koo, J; Snyder, AJ; Campbell, K; Miller, E; O'conner, A; Grompe, M; Mehta, PA; Myers, KC; Davies, SM. Hepatocyte senescence and persistent liver injury in Fanconi anemia. Haematologica. 2025; 110(8):1870-1874.

Koo, J; Webster, A; Myers, KC; Davies, SM; Davies, SM; Sabulski, A. Transcriptomic Alterations and Clonal Evolution Identifies a Pre-Emptive Indication for Hematopoietic Stem Cell Transplant in Fanconi Anemia. Transplantation and Cellular Therapy. 2025; 31(2):s308-s309.

Koo, J; Lake, KE; Langenberg, L; Anderson, J; Edwards, SL; Teusink-Cross, A; Romick-Rosendale, L; Sabulski, A; Jodele, S; Davies, SM. Pravastatin Prophylaxis Is Safe and Feasible in Children and Young Adults Undergoing Allogeneic HSCT: A Prospective, Single Arm Cohort Study. Transplantation and Cellular Therapy. 2025; 31(2):s153-s154.

Koo, J; Miller, E; O'conner, A; Campbell, KM; Grompe, M; Myers, KC; Mehta, PA; Davies, SM. Beyond Graft-Vs-Host Disease: The Role of Cellular Senescence in Persistent Liver Injury in Fanconi Anemia after HSCT. Transplantation and Cellular Therapy. 2025; 31(2):s311-s312.

Koo, J; Langenberg, L; Zhao, X; Setchell, KR; Lake, KE; Luebbering, N; Walter, E; Lane, A; Myers, KC; Reynaud, D; Sabulski, A; Teusink-Cross, A; Jodele, S; Davies, SM. Lipid dysregulation after hematopoietic stem cell transplant. Haematologica. 2025.

Koo, J; Haney, M; Schwarz, D; Kim, J; Schwarz, L; Steltz, S; Korn, E; Cheng, L; Loveless, S; Cooper, R; Shimamura, A; Myers, K; Grover, A; Wehrman, A. Liver disease in shwachman-diamond syndrome: A report from the shwachman-diamond syndrome registry. Blood. 2025; 146(Supplement 1):1436.

Koo, J; Hornung, LN; Howell, J; Lawhorn, E; Comstock, D; Reilly, C; Ferrer, A; Mangaonkar, A; Barredo, B; Churpek, J; Patel, B; Savage, S; Giri, N; Myers, K. Bone matters: Defining the burden of skeletal disease in telomere biology disorders. Blood. 2025; 146(Supplement 1):6747.

Koo, J; Myers, KC. Immunodeficiency in TBDs: making the lymphocyte count. Blood. 2025; 146(10):1148-1150.

Kotch, C; Gomes, A; Schatz, KS; Dombi, E; Brown, S; Gross, AM; Alves, M; Perreault, S; Mueller, S; Reddy, AT; Tonsgard, J; Weiss, BD; Widemann, B; Fisher, MJ. The spectrum of pathogenic NF1 variants in participants enrolling on clinical trials of MEK inhibitors for plexiform neurofibroma. Human Genetics. 2025; 144(11-12):1199-1206.

Kraft, IL; Akshintala, S; Gross, A; Dombi, E; Turkbey, B; Bednarova, S; Ward, JF; Yedururi, S; Merino, M; Pinto, PA; Widemann, BC; Shern, JF; Waguespack, SG; Glod, J. The Prostate is a Common Site of Disease in Patients with MEN2B and Medullary Thyroid Carcinoma. Endocrine-Related Cancer. 2025.

Krisch, JM; Ermoian, RP; Indelicato, DJ; Lee, JY; Perentesis, JP; Perkins, SM; Laack, NN; Chang, JH; Macewan, IJ; Wolden, SL; Wang, D; Yock, TI; Aridgides, PD. Outcomes following radiation therapy for embryonal tumor with multilayered rosettes (ETMR): results from the Pediatric Proton/Photon Consortium Registry (PPCR). Journal of Neuro-Oncology. 2025; 174(2):369-380.

Krishnan, A; Miles, LA; Challen, GA. Cell-extrinsic factors contribute toward myeloid-biased expansion in Tet2-mutant clonal hematopoiesis. Experimental Hematology. 2025; 148:104816.

Kurtz, K; Ma, E; Chi, Y-Y; Malvar, J; Tan, Y; Schafer, E; Pauly, M; Kaplan, J; Pommert, L; Rossoff, J; Graff, Z; Shin-Kashiyama, E; Wayne, A; Bhojwani, D. Identifying barriers to clinical trial enrollment for children with relapsed or refractory hematologic malignancies. Blood. 2025; 146(Supplement 1):4404-4404.

Kusne, Y; Badar, T; Lasho, T; Marando, L; Mangaonkar, AA; Finke, C; Foran, JM; Al-Kali, A; Palmer, J; Arana Yi, C; Litzow, MR; Chlon, T; Ferrer, A; Patnaik, MM. Prevalence of cytopenia(s) and somatic variants in patients with DDX41 mutant germline predisposition syndrome. British Journal of Haematology. 2025; 206(4):1109-1120.

Kusoski, C; Mehta, PA; Markham, J; Zhao, J; Setchell, KDR; Murphy, M; Teusink-Cross, A. Utilization of Intravenous Posaconazole in Pediatric Patients Undergoing Hematopoietic Stem Cell Transplant. Transplantation and Cellular Therapy. 2025; 31(12):1033.e1-1033.e11.

Kusoski, CL; Mehta, PA; Markham, J; Murphy, M; Teusink-Cross, A. Higher Dose Intravenous Posaconazole Is Safe and Necessary for Achievement of Therapeutic Targets and Prevention of Infections in Pediatric Hematopoietic Stem Cell Transplant Patients. Transplantation and Cellular Therapy. 2025; 31(2):s546.

Lafay-Cousin, L; Cansanay, D-R; Erker, C; Ratterman, E; Schlosser, MP; Nobre, L; Ronsley, R; Magimairajan, V; Pillay-Smiley, N; Cluster, A; Robinson, G; Dufour, D; Rutkowski, S; Bouffet, E. Medulloblastoma of early childhood. Salvage and outcome after initial CSI sparing approaches. OncoDaily Medical Journal. 2025.

Lamoureux, A-A; Fisher, MJ; Lemelle, L; Pfaff, E; Amir-Yazdani, P; Kramm, C; De Wilde, B; Kazanowska, B; Hutter, C; Pfister, SM; Jones, C; Doz, F; Laetsch, TW; Perreault, S. Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene Fusions. Clinical Cancer Research. 2025; 31(3):561-572.

Lane, A. Optimal relevant subset designs in nonlinear models. Canadian Journal of Statistics, The. 2025; 53(3).

Lang, AC; Mosley, C; Rosen, BL; Oke, E; Thompson, AA; Barriteau, C; Schwartz, L; Smith-Whitley, K; Crosby, LE; Shook, LM. Co-designing educational materials about SARS-CoV-2 (COVID-19) vaccines with individuals with sickle cell disease (SCD) and their families. Journal of Sickle Cell Disease. 2025; 2(1).

Lange, KR; De Blank, P; Xing, M; Mirzaei, S; Srivastava, DK; Oeffinger, K; Neglia, J; Krull, K; Nathan, PC; Howell, R; Armstrong, GT; Brinkman, T; Bowers, DC; Okcu, MF. Late Morbidity and Mortality in Survivors of Childhood Ependymoma: A Report from the Childhood Cancer Survivor Study (CCSS). Cancers. 2025; 17(22).

Langenberg, L; Abdullah, S; Lies, E; Benoit, SW; Ramos, KN; Jodele, S; Davies, SM; Sabulski, A. Urine Kidney Injury Biomarkers Predict TMA Risk in Pediatric HSCT Recipients. Transplantation and Cellular Therapy. 2025; 31(2):s314.

Langenberg, L; Jodele, S; Davies, SM; Sabulski, A. Supar Is a Novel and Powerful Biomarker of TMA and Kidney Injury after HSCT. Transplantation and Cellular Therapy. 2025; 31(2):s313-s314.

Largaespada, D; Williams, K; Larsson, A; Keller, B; Stehn, C; Chaney, K; Williams, R; Bhunia, M; Draper, G; Jubenville, T; Hudson, W; Galvin, R; Moertel, C; Ratner, N. DDDR-42. Modeling and Translating Precision Therapies for NF1-Associated Tumors Across the Disease Spectrum. Neuro-Oncology. 2025; 27(Supplement_5):v172-v172.

Latham, TS; Babich, SM; Yego-Kosgei, F; Czabanowska, K; Ware, RE. Building capacity for sickle cell stroke prevention in low-resource settings. Discover Public Health. 2025; 22(1):881.

Latham, T; Kiyaga, C; Hernandez, A; Nakafeero, M; Kadde, N; Khainza, P; Stuber, S; Ndeezi, G; Aceng, J; Ware, R. Health status of Ugandan children born with sickle cell anemia and congenital HIV identified through newborn screening. Blood. 2025; 146(Supplement 1):2668.

Latham, TS; Ware, RE; Shook, LM. Assessing educational needs of sickle cell anemia healthcare providers in sub-Saharan Africa and the Caribbean. Frontiers in Public Health. 2025; 13:1693285.

Latham, TS; Czabanowska, K; Babich, S; Yego-Kosgei, F; Shook, LM; Ware, RE. Primary Stroke Screening and Hydroxyurea Treatment for Sickle Cell Anemia in Pediatric Healthcare Settings in East and Central Africa: A Narrative Review of Capacity Gaps and Opportunities. Public Health Reviews. 2025; 46:1608359.

Lazow, M; Bobbey, A; Szabo, S; Fuller, C; White, W; Mcneely, D; Gibson, L; Brady, S; Palmer, J; Mardis, E; Troyer, K; Fouladi, M; Salloum, R; Trout, A. IMGP-04. Targetable somatostatin receptor expression assessed by DOTATATE PET imaging in children and young adults with recurrent/progressive high-risk central nervous system (CNS) tumors: Initial screening results from the CONNECT2007 Lutathera Phase I/II trial. Neuro-Oncology. 2025; 27(Supplement_5):v311-v311.

Lee, JJY; Tao, R; You, Z; Haldipur, P; Erickson, AW; Farooq, H; Hendriske, LD; Abeysundara, N; Richman, CM; Wang, EY; Millen, KJ; Huang, LF; Northcott, PA; Taylor, MD. ZIC1 is a context-dependent medulloblastoma driver in the rhombic lip. Nature Genetics. 2025; 57(1):88-102.

Lemberg, KM; Gross, AM; Sproule, LM; Liewehr, DJ; Dombi, E; Baldwin, A; Steinberg, SM; Bornhorst, M; Lodish, M; Blakeley, JO; Widemann, BC. Anthropometric measurements of children with neurofibromatosis type I: impact of plexiform neurofibroma volume and treatment. Pediatric Research. 2025; 97(6):1918-1928.

Lenahan, SF; Blackmore, A; Fenchel, M; Thomas, E; Palumbo, JS; Tarango, C. Recurrent thrombosis and major bleeding in children treated for VTE. Blood advances. 2025; 9(15):3824-3831.

Levine, AB; Bennett, J; Patil, P; Burns, I; Siddaway, R; Li, C; Haizel-Cobbina, J; Rana, M; Yuditskiy, R; Son, A; Rutka, JT; Dewan, MC; Tabori, U; Hawkins, CE. Integrated clinical and molecular landscape of disseminated pediatric low-grade glioma. Neuro-Oncology. 2025.

Li, J; Merkel, E; Grier, D; Zimmermann, N; Hodjat, P; Sabharwal, S; Breese, EH; Lorsbach, RB. Maternal-Fetal Transmission of Diffuse Large B-Cell Lymphoma. Pediatric Blood and Cancer. 2025; e32174.

Li, J; Bai, J; Pham, VT; Hashimoto, M; Sezaki, M; Shi, Q; Jin, Q; He, C; Armstrong, A; Li, T; Luan, Y; Zeng, H; Andreassen, PR; Huang, G. Loss of Cpt1a results in elevated glucose-fueled mitochondrial oxidative phosphorylation and defective hematopoietic stem cells. Journal of Clinical Investigation. 2025; 135(5).

Li, W; Xu, M; Cheng, M; Wei, J; Zhu, L; Deng, Y; Guo, F; Bi, F; Liu, M. Current Advances and Future Directions for Sensitizing Gastric Cancer to Immune Checkpoint Inhibitors. Cancer Medicine. 2025; 14(14):e71065.

Li, C; Xie, Q; Ghosh, S; Cao, B; Du, Y; Vo, GV; Huang, TY; Spruck, C; Carpenter, RL; Wang, YA; Lu, QR; Nephew, KP; Shen, J. SUV39H1 maintains cancer stem cell chromatin state and properties in glioblastoma. JCI Insight. 2025; 10(5).

Li, Q; Liao, Y; Zeng, J; Hu, S; Li, C; Whitsett, JA; Zheng, Y; Luo, F; Xu, C; He, T; Lin, X; Wan, H. KLF5 Shapes Developing Respiratory Tubules by Inhibiting Actin Asymmetry in Epithelial Cells. American Journal of Respiratory Cell and Molecular Biology. 2025; 72(6):663-677.

Lichtenstein, DA; Sridharan, A; Khoury, R; Grimley, MS; Rubinstein, JD; Lutzko, CM; Wang, YM. Effect of Clinically Relevant Immunosuppressants on Viral Specific T-Cell (VST) in Vitro Function. Transplantation and Cellular Therapy. 2025; 31(2):s509-s510.

Lin, AM; Bergus, KC; Bricker, J; Fallat, M; Hertweck, SP; Hewitt, G; Lutz, C; Aldrink, JH; Bence, C; Breech, L; St Peter, SD; Asti, L; Deans, K; Minneci, PC. Use of Ovarian Tumor Markers in Prediction of Malignancy Risk in Pediatric and Adolescent Patients. Journal of Surgical Research. 2025; 315:839-846.

Lin, S; Kotliar, M; Vallabh, S; Ptasinska, A; Assi, SA; Wunderlich, M; Bonifer, C; Barski, A; Mulloy, JC. Fusion-specific chromatin profiles mediate transcriptional heterogeneity in MLL-rearranged acute lymphoblastic leukemia. Blood advances. 2025; 9(4):856-861.

Lin, Y; Zheng, Y. Structural Dynamics of Rho GTPases. Journal of Molecular Biology. 2025; 437(3):168919.

Ling, T; O'brien, C; St-Germain, J; Rondeau, V; Shi, M; Berman, JM; Cepa, AK; Saez Raez, P; Wunderlich, M; Carter, K; Hope, K; D'alessandro, A; Raught, B; Jones, CL. Glutaredoxin 2 is essential for AML survival through mitochondrial permeability transition pore regulation. Blood. 2025.

Little, P; Al Ghriwati, N; Siegel, A; Toledo-Tamula, MA; Curlee, MS; Baker, M; Rogge, RD; Yohe, M; Gross, A; Martin, S. A Pilot Acceptance and Commitment Intervention for Parents of Children With RASopathies. Clinical Practice in Pediatric Psychology. 2025; 13(1):37-48.

Littner, L; Hu, J; Manuel, M; Gerber, C; Tarango, C. Inhibitors and Obesity: The Prevalence and Strength of Association in People With Haemophilia. Haemophilia. 2025; 31(6):1226-1235.

Littner, L; Thomas, E; Mooney, L; Doyle, J; Hendrickson, J; Tarango, C. Improving Time to Bleeding Disorder Treatment in the Emergency Department. Pediatric Blood and Cancer. 2025; 72(4):e31570.

Liu, B; Sajiki, Y; Littlefield, N; Hu, Y; Stuart, WD; Sridharan, A; Cui, X; Siefert, ME; Araki, K; Ziady, AG; Shi, D; Whitsett, JA; Maeda, Y. PBAE-PEG-based lipid nanoparticles for lung cell-specific gene delivery. Molecular Therapy. 2025; 33(3):1154-1165.

Liu, K; Kang, Z; Yang, M; Chen, F; Xia, M; Dai, W; Zheng, S; Chen, H; Lu, QR; Zhou, W; Lin, Y. The role of oligodendrocyte progenitor cells in the spatiotemporal vascularization of the human and mouse neocortex. Glia. 2025; 73(1):140-158.

Lucas, C-HG; Gross, AM; Romo, CG; Dehner, CA; Lazar, AJ; Miettinen, M; Pekmezci, M; Quezado, M; Rodriguez, FJ; Stemmer-Rachamimov, A; Viskochil, D; Perry, A. Consensus recommendations for an integrated diagnostic approach to peripheral nerve sheath tumors arising in the setting of Neurofibromatosis Type 1. Neuro-Oncology. 2025; 27(3):616-624.

Luo, Z; Xia, M; Zhang, F; Xin, D; Rao, R; Kiang, KM; Berry, K; Xiong, Y; Liu, H; Lin, Y; Li, H; Taylor, MD; Zhou, W; Lu, QR. CNSC-41. IDENTIFICATION AND VALIDATION OF TRANSITIONAL CEREBELLAR PROGENITORS (TCP) IN THE RHOMBIC LIP OF THE HUMAN FETAL CEREBELLUM. Neuro-Oncology. 2025; 27(Supplement_5):v63-v63.

Lust, H; Schultz, LM; Kwon, S; Roloff, GW; Aldoss, I; Baggott, C; John, S; Rossoff, JE; Mcnerney, KO; Fabrizio, VA; Sutherland, KC; Shah, BD; Muffly, L; Faramand, R. Real-world outcomes for young adult patients receiving CD19 CAR T-cell therapy. Blood advances. 2025; 9(11):2763-2772.

Lyons, AT; Haizel-Cobbina, J; Levine, A; Bishay, AE; Jew, N; Li, C; Patil, P; Bennett, J; Siddaway, R; Yuditskiy, R; Rutka, JT; Tabori, U; Hawkins, CE; Dewan, MC. Disseminated pediatric low-grade glioma and hydrocephalus: a multinational consortium analysis of incidence and mortality. Journal of Neurosurgery: Pediatrics. 2025; 1-14.

Macaraeg, M; Baker, E; Handorf, E; Matt, M; Baker, EK; Brunner, H; Grom, AA; Henrickson, M; Huggins, J; Zhang, W; Lee, P; Marsh, R; Schulert, GS. Clinical, Immunologic, and Genetic Characteristics in Patients With Syndrome of Undifferentiated Recurrent Fevers. Arthritis & Rheumatology. 2025; 77(5):596-605.

Machogu, E; Aanyu-Tukamuhebwa, H; Mellencamp, K; Birungi, I; Namutangula, B; Namazzi, R; Latham, T; Opoka, R; Ware, R; Davis, SD; John, C. Benefits of Hydroxyurea in Mitigating Early Onset Lung Disease in Children With Sickle Cell Anemia. American Journal of Respiratory and Critical Care Medicine. 2025; 211(Abstracts):a1272-a1272.

Maier, S; Auletta, JJ; Badia, P; Cook, E; Craddock, JA; Culbertson, C; Daraiseh, N; Davies, SM; Desalvo, AM; Diaz, J; Nishitani, M; Snyder, AJ; Dandoy, CE; Parker, L. Establishing a Quality Improvement Education Platform in the Engraft Learning Network. Transplantation and Cellular Therapy. 2025; 31(2):s501.

Malec, L; Mathias, M; Dunn, AL; Nolan, B; Wong, N; Bystrická, L; Khan, U; Neill, G; Santagostino, E; Gunawardena, S; Tarango, C; Peyvandi, F. Post hoc analysis of bleeding episodes and clinically relevant pharmacokinetic parameters among children <12 years old with severe hemophilia A receiving once-weekly efanesoctocog alfa prophylaxis in the XTEND-Kids phase 3 multinational trial. Journal of Thrombosis and Haemostasis. 2025; 23(11):3481-3491.

Malec, LM; Simpson, M; Khan, U; Neil, G; Mamikonian, L; Tarango, C. HTRS2025.P1.6 Clinical Outcomes Over 2 Years of Once-Weekly Efanesoctocog Alfa Treatment in Children From North America With Severe Hemophilia A in the Phase 3 XTEND-ed Long-Term Extension Study. Research and Practice in Thrombosis and Haemostasis. 2025; 9:103026.

Mani, B; Hudda, Z; Lawhorn, E; Frias, O; Myers, K; Burns, K; Howell, JC. SAT-218 Longitudinal outcomes of fertility potential in female pediatric hematopoietic stem cell transplant survivors. Journal of the Endocrine Society. 2025; 9(Supplement_1):bvaf149.1785.

Manjrekar, P; Sabulski, A; Lies, E; Dandoy, CE; Davies, SM; Laskin, B; Jodele, S. The HCT Protein Shake: Moderate and Severe Proteinuria Are Specific to TA-TMA. Transplantation and Cellular Therapy. 2025; 31(2):s145.

Maron, G; Boeckh, MJ; Papanicolaou, G; Gomez, C; Prasad, V; Dara, J; Elgarten, C; Kumar, M; Wynn, R; Lion, T; Fukushima, K; Maher, R; Azie, N; Grimley, M. P-103. Adenoviremia Clearance Following Treatment with Intravenous (IV) Brincidofovir (BCV) in Immunocompromised Patients is Associated with Positive Clinical Disease Response: Preliminary Outcomes from the ATHENA Phase IIa Study. Open Forum Infectious Diseases. 2025; 12(Supplement_1):ofae631.310.

Marsh, R; Khoury, R; Mizuno, K; Hosawi, A; Cottrell, C; Nguyen, E; Landon, B; Chandra, S; Jordan, M; Kumar, A; Bleesing, J; Davies, S; Moore, C; Mehta, P. Precision Alemtuzumab Dosing Results in Day 0 Target Range Achievement in 80% of IEI Patients and Minimizes Risks of GVHD, Clinically Significant Mixed Chimerism, and Secondary Graft Failure. Journal of Human Immunity. 2025; 1(CIS2025).

Marsh, RA; Bleesing, JJ; Chiang, SCC. Diagnostic testing for hemophagocytic lymphohistiocytosis. Journal of Immunological Methods. 2025; 537:113816.

Matt, MG; Drozdov, D; Bendstrup, E; Glerup, M; Hauge, E-M; Masmas, T; Schneider, EC; Zeilhofer, UB; Abu-Arja, RF; Driest, KD; Chandra, S; Grom, A; Schulert, GS; Marsh, RA. Allogeneic haematopoietic stem-cell transplantation for children with refractory systemic juvenile idiopathic arthritis and associated lung disease: outcomes from an international, retrospective cohort study. The Lancet Rheumatology. 2025; 7(4):e243-e251.

Maurer, A; Wang, T; Defilipp, Z; Devos, J; Farhadfar, N; Khandelwal, P; Spellman, S; El Jurdi, N; Lee, S; Soiffer, R. Reduced chronic graft versus host disease after allogeneic HSCT with cryopreserved peripheral blood stem cell grafts: A CIBMTR analysis. Blood. 2025; 146(Supplement 1):933-933.

Mccormack-Spivey, S; Sabulski, A; Davies, SM; Chandra, S. Defining and Assessing Poor Graft Function after Allogeneic HSCT in Children and Young Adults. Transplantation and Cellular Therapy. 2025; 31(2):s317-s318.

Mccormack-Spivey, S; Laskin, B; Seif, AE; Blackard, JT; Odegard, E; Kleiboeker, S; Jodele, S; Bourgeois, T; Zee, J; Davies, SM; Sabulski, A. The First Prospective Screening Study of BK Polyomavirus (BKPyV) Hemorrhagic Cystitis after HSCT. Transplantation and Cellular Therapy. 2025; 31(2):s513-s514.

Mccormack-Spivey, S; Strecker, L; Webster, A; Davies, SM; Sabulski, A. Plasma LILRA6 Levels Influence BK Polyomavirus Cystitis after HSCT. Transplantation and Cellular Therapy. 2025; 31(2):s514-s515.

Mcgrady, ME; Ketterl, TG; Webster, RT; Burns, MMK; Bills, SE; Burke, M; Szulczewski, L; Brock, MY; Schwartz, LE; Herriott, JK; Hommel, KA; Pai, ALH; Mara, CA; Norris, RE. Feasibility Trial of a Tailored Adherence-Promotion Intervention for Adolescents and Young Adults With Cancer. Pediatric Blood and Cancer. 2026; 73(1):e32127.

Mcgrady, ME; Webster, RT; Burke, M; Gomez, C; Breen, G; Herriott, JK; Norris, RE; Ketterl, TG. Developing Behavior Change Model-Informed and Participant-Engaged Retention Strategies for Adolescents and Young Adults With Cancer Enrolled on Behavioral and/or Psychosocial Trials. Pediatric Blood and Cancer. 2025; 72(5):e31583.

Mehta, PA; Nelson, A; Loveless, S; Lane, A; Fukuda, T; Teusink-Cross, A; Elder, D; Lagory, D; Miller, E; Cancelas, JA; Edwards, S; Chihanga, T; Wells, SI; Davies, SM. Phase 1 study of quercetin, a natural antioxidant for children and young adults with Fanconi anemia. Blood advances. 2025; 9(8):1927-1939.

Mejía-Ramírez, E; Picazo, PI; Walter, B; Montserrat-Vazquez, S; Affuso, F; Wieser, S; Pezzano, F; Reymond, L; Castillo-Robles, J; Matteini, F; Ruprecht, V; Zheng, Y; Petrone, P; Florian, MC. Targeting RhoA nuclear mechanoactivity rejuvenates aged hematopoietic stem cells. Nature Aging. 2026; 6(1):68-87.

Merkle, S; Lecras, T; Ricci, K; Hammill, A; Engel, E. Use of angiopoietin-2 as a biomarker in vascular anomalies beyond complex lymphatic anomalies. Blood. 2025; 146(Supplement 1):4877.

Merli, P; Jodele, S; Cook, E; Myers, KC; Lane, A; Ryhänen, S; Cefalo, MP; Quagliarella, F; Davies, SM; Teusink-Cross, A; Kohorst, M; Corsetti, T; Locatelli, F; Sabulski, A. Emapalumab for the Treatment of Immune-Mediated Graft Failure after HSCT. Bone Marrow Transplantation. 2025; 60(3):406-411.

Mestre, J; Chaparro-González, L; Granada, I; Mallo, M; Cid, E; Mancini, E; Calvete, O; Risueño, RM; Starczynowski, DT; Solé, F. Integrated cytogenetic and genomic profiling of the MDS-L cell line. Molecular Cytogenetics. 2025; 18(1):11.

Meyer, R; Orndorff, L; Engel, H; Hoback, P; Spivey, S; Mikut, K; Spears, K; Clark, A; Sarver, S; Dandoy, CE. Nurse Driven Central Line Rounding Utilized to Improve Bone Marrow Transplant Patient Outcomes: An Update. Transplantation and Cellular Therapy. 2025; 31(2):s451.

Miao, L; Lu, Y; Nusrat, A; Fan, G; Zhang, S; Zhao, L; Wu, C-L; Guo, H; Huyen, TLN; Zheng, Y; Wan, LQ; Zhou, B; Evans, SM; Wu, M. Tunneling nanotube-like structures regulate distant cellular interactions during heart formation. Science. 2025; 387(6739):eadd3417.

Miles, LA. Runx2 takes center stage in regulating HSC expansion. Blood. 2025; 146(26):3135-3136.

Mizuno, K; Teusink-Cross, A; Sabulski, A; Davies, SM; Jodele, S. Unraveling the Challenges of Non-Responders to the Eculizumab Treatment with High-Risk Hematopoietic Stem Cell Transplant-Associated Thrombotic Microangiopathy (TA-TMA) Transplantation and Cellular Therapy. 2025; 31(2):s542-s543.

Monagle, P; Azzam, M; Bercovitz, R; Betensky, M; Bhat, R; Biss, T; Branchford, B; Brandão, LR; Chan, AKC; Faustino, EVS; Wilson, HP; Woods, G; Zia, A; Mustafa, RA. American Society of Hematology/International Society on Thrombosis and Haemostasis 2024 updated guidelines for treatment of venous thromboembolism in pediatric patients. Blood advances. 2025; 9(10):2587-2636.

Mooney, JT; Sinha, C; Bakshi, N; Nuñez, A; Adkins, T; Thomas, S; Beasley, K; Akintobi, T; Crosby, L; Kashikar-Zuck, S; Dampier, C; Myer, GD; Kesar, T; Quinn, CT; Sil, S. Physical activity among adolescents and young adults living with chronic pain and sickle cell disease: a qualitative examination. Journal of Pediatric Psychology. 2025; 50(12):1079-1087.

Mooney, J; Adkins, T; Heatly, J; Howard, V; Dampier, C; Nuñez, A; Williams, J; Smith, E; Crosby, L; Kashikar-Zuck, S; Quinn, C; Kesar, T; Myer, G; Sil, S. Randomized controlled trial-in-progress of an interdisciplinary treatment program for youth with chronic SCD pain: Integrative strong body and mind training for sickle cell disease (I-STRONG) Blood. 2025; 146(Supplement 1):4753.

Moscato, EL; Fisher, AP; Patronick, J; Pillay-Smiley, N; Gerhardt, CA; Salloum, R; Wade, SL. Quality of Life for Rural and Appalachian Pediatric Brain Tumor Survivors in Ohio and Kentucky. Clinical Practice in Pediatric Psychology. 2025; 13(1):11-16.

Munshi, P; Wang, T; Mccurdy, S; Nath, R; Huffman, C; Farhadfar, N; Defilipp, Z; Khandelwal, P; Saber, W; Spellman, S; Jurdi, NE; Lee, S; Zhou, Z. Post-transplant cyclophosphamide based GVHD prophylaxis in HLA-matched related and unrelated donor hematopoietic cell transplantation in adults with hematologic malignancies undergoing myeloablative conditioning: A CIBMTR analysis of 8,272 participants. Blood. 2025; 146(Supplement 1):931.

Murphy, CR; Liu, C; Courter, J; Griffin, C; Scaggs Huang, F; Miller-Handley, H; Grimley, MS; Danziger-Isakov, L; Otto, WR. Receipt of Fluoroquinolone Prophylaxis is not Associated With Development of Vancomycin-Resistant Enterococcus Colonization During Pediatric Hematopoietic Cell Transplantation. Journal of the Pediatric Infectious Diseases Society. 2025; 14(3).

Muteti, M; Akoko, E; Nyakundi, C; Mochamah, G; Makale, J; Ombati, P; Tawa, B; Nyanjom, S; Boateng, LA; Ware, RE; Williams, TN; Uyoga, S. Erythrocyte alloimmunization in children with sickle cell anemia living in Kilifi, Kenya. Blood Global Hematology. 2025; 1(2):100016.

Myers, KC; Andresen, F; Goldberg, B; Weller, E; Reilly, C; Nakano, TA; Bertuch, AA; Geddis, A; Joos, M; Coyne, K; Brundige, K; Loveless, S; Cheng, L; Shimamura, A. SUPERIOR SURVIVAL FOLLOWING HEMATOPOIETIC STEM CELL TRANSPLANTATION FOR HIGH-RISK MARROW FEATURES IN PATIENTS WITH SHWACHMAN-DIAMOND SYNDROME. EJC Paediatric Oncology. 2025; 6:100336.

Myers, K; Donadieu, J; Goldberg, B; Delafoy, M; Zeidler, C; Wan, Y; Zhu, X; Cesaro, S; Cipolli, M; Watanabe, K; Warren, A; Geddis, A; Weller, E; Shimamura, A. Low hematologic event-free survival with age in shwachman-diamond syndrome. Blood. 2025; 146(Supplement 1):748-748.

Myers, KC; Davies, SM; Lutzko, C; Wahle, R; Grier, DD; Aubert, G; Norris, K; Baird, DM; Koga, M; Ko, AC; Amano, T; Amano, M; Yu, H; Ko, MSH. Clinical Use of ZSCAN4 for Telomere Elongation in Hematopoietic Stem Cells. NEJM Evid. 2025; 4(3):EVIDoa2400252.

Myers, KC; Skala, EJ; Ghandikota, S; Jegga, AG; Mousa, N; Siefert, ME; Lane, A; Reffatto, V; Towe, C; Luebbering, N; Bridgeland, A; Goldfarb, S; Davies, SM; Ziady, AG. Blood proteomics of paediatric bronchiolitis obliterans syndrome after hematopoietic cell transplant. ERJ Open Research. 2025; 00745-02025.

Naik, S; Selukar, S; Talleur, AC; Deshpande, S; Llaurador Caraballo, G; Fabrizio, VA; Rouce, RH; Zeng, XL; Vatsayan, A; Rossoff, J; Nguyen, KP; Baggott, C; Schultz, LM; Mcnerney, KO. Characterization and prediction of prolonged severe neutropenia in pediatric patients receiving tisagenlecleucel. Blood advances. 2025; 9(19):5070-5084.

Nalapareddy, K; Haslam, DB; Kissmann, A-K; Alenghat, T; Stahl, S; Rosenau, F; Zheng, Y; Geiger, H. Microbiota from young mice restore the function of aged ISCs. Stem Cell Reports. 2026; 102788.

Namazzi, R; Mellencamp, KA; Opoka, RO; Datta, D; Lima-Cooper, G; Liepmann, C; Sherman, J; Rodriguez, A; Kazinga, C; Ware, RE; Abreu, M; Schwantes-An, T-H; John, CC; Conroy, AL. Circulating Immune Complexes and Glucose-6-Phosphate Dehydrogenase Deficiency Predict Recurrent Blackwater Fever in Ugandan Children With Severe Malaria. Journal of Infectious Diseases. 2025; 232(2):285-297.

Nath, K; Zhang, M-J; Bye, M; Abid, MB; Benjamin, C; Betts, B; Bhatt, NS; Arrieta Bolaños, E; Bolon, Y-T; Gadalla, SM; Shaw, BE; Spellman, SR; Choe, H; Shaffer, BC. Transplant outcomes using older matched sibling donors compared with young alternative donors: a CIBMTR analysis. Blood advances. 2025; 9(14):3469-3478.

Naymagon, L; Roehrs, P; Hermiston, M; Connelly, J; Bednarski, J; Boelens, J-J; Chandrakasan, S; Dávila Saldaña, B; Henry, MM; Satwani, P; Teachey, D; Behrens, EM; Canna, SW; Kumar, A. Perspectives on the current diagnostic and treatment paradigms in secondary hemophagocytic lymphohistiocytosis (HLH). Orphanet Journal of Rare Diseases. 2025; 20(1):200.

Neidemire-Colley, L; Zhao, Q; Miller, EG; Langenberg, L; Elder, P; Hahn, TE; Bejanyan, N; Davies, SM; Ranganathan, P; Vasu, S. Soluble Fms-like Tyrosine Kinase-1 (sFlt-1) As a Clinical Biomarker for Individual Susceptibility to Post-Transplant Complications: A Report from the MIDAS Consortium. Transplantation and Cellular Therapy. 2025; 31(2):s26-s27.

Nguyen, P; Indelicato, DJ; Esterman, A; Paulino, AC; Ermoian, RP; Laack, NN; Perkins, SM; Mangona, V; Mihalcik, S; Lee, J; Perentesis, JP; Macewan, I; Le, H; Yock, TI. Acute Toxicities of Proton Craniospinal Irradiation in Pediatric Medulloblastoma: A Pediatric Proton/Photon Consortium Registry (PPCR) Study. International Journal of Particle Therapy. 2025; 16:100747.

Nguyen, TH; Satwani, P; Kumar, D; Kapoor, U; Malik, S; Prince, C; Montminy, T; Smiley, K; Martinez, M; Goldner, D; Fazlollahi, L; Rytting, HB; Romero, R; Chandrakasan, S. Systemic T-cell activation and IFN-γ activity in indeterminate severe hepatitis are reminiscent of hemophagocytic lymphohistiocytosis: Implications for T-cell- and IFN-γ-directed therapies. Journal of Allergy and Clinical Immunology. 2025; 155(1):199-212.

Nieves, RM; Latham, T; Marte, N; Berges, M; Sánchez, LM; Urcuyo, G; Florencio, C; Gonzalez, C; Del Villar, P; Chen, S; Schultz, WH; Lane, AC; Mena, R; Ware, RE. Stroke prevention in Hispanic children with sickle cell anemia: the SACRED trial. Blood advances. 2025; 9(8):1791-1800.

Niss, O; Morin, CE; Hashemi, S; Alsaied, T; Lang, SM; Taylor, MD; Tasset, M; Malik, P; Quinn, CT. Longitudinal changes and predictors of cardiac extracellular volume fraction in sickle cell anemia. Blood Red Cells Iron. 2025; 1(3).

Niss, O; Ware, RE; Quinn, CT. A New First-Line Option for Pediatric ITP-Incremental Progress or Paradigm Shift? Journal of the American Medical Association (JAMA). 2025; 334(20):1802-1803.

Niss, O; Fenchel, M; Abrams, C; Quinn, C; Kutlar, A. Reassessing voxelotor safety and efficacy: Real-world outcomes from the ASH research collaborative data hub. Blood. 2025; 146(Supplement 1):6226-6226.

Niss, O; Morin, C; Hashemi, S; Alsaied, T; Lang, S; Tasset, M; Taylor, M; Malik, P; Quinn, C. Impact of disease genotype and severity of anemia on myocardial extracellular volume fraction in sickle cell disease (SCD) and non-SCD hemolytic anemias. Blood. 2025; 146(Supplement 1):2957.

Nnodu, O; Awuonda, B; Chirande, L; Kiyaga, C; Segbefia, C; Chunda-Liyoka, C; Franklin, P; Zapfel, A; Benoit, M; Thompson, A; Coetzer, T; Ware, R; Novelli, E; Green, NS. The ASH consa consortium on newborn screening in Africa for sickle cell disease: Interim updates of progress in screening, follow-up and supporting initiatives. Blood. 2025; 146(Supplement 1):944-944.

Ntoumaziou, A; Husami, A; Risinger, M; Elgammal, Y; Voulgaridou, A; Leister, J; Seu, K; Zhang, W; Kalfa, T. Hereditary spherocytic pyropoikilocytosis: Expanding the clinical and genetic spectrum of red blood cell membrane disorders. Blood. 2025; 146(Supplement 1):4667.

O'brien, C; Nursimulu, N; Tyagi, A; Culp-Hill, R; Arruda, A; Murphy, T; Minden, MD; Kent, A; Stevens, B; Pollyea, DA; Hope, K; Kumar, S; Reisz, JA; D'alessandro, A; Jones, CL. Plasma lipid levels predict chemotherapy response and survival in acute myeloid leukemia. Blood. 2025; 146(21):2589-2596.

O'brien, C; Jones, CL. Unraveling lipid metabolism for acute myeloid leukemia therapy. Current Opinion in Hematology. 2025; 32(2):77-86.

Oved, JH; Marsh, RA; Petrovic, A. Haematopoietic stem cell transplant for inborn errors of immunity-Who and when? British Journal of Haematology. 2025; 207(3):750-753.

Padarti, A; Quinn, CT; Kwiatkowski, JL; Mcnaull, M; Kirkham, FJ; Plumb, P; Hynan, LS; Dowling, MM. Prevalence of Antiplatelet and Anticoagulation Therapy in Children with Sickle Cell Anemia and Stroke. Pediatr Stroke. 2025; 11:111-140.

Papini, C; Mirzaei, S; Xing, M; Tonning Olsson, I; Salloum, R; De Blank, PMK; Lange, KR; King, TZ; Srivastava, D; Leisenring, WM; Robison, LL; Armstrong, GT; Krull, KR; Brinkman, TM. Neurocognitive outcomes and functional independence in adult survivors of childhood medulloblastoma diagnosed over 3 decades. Neuro-Oncology. 2025; 27(1):254-266.

Pappano, E; Eskandari, N; Ruiz, MA; Ren, G; Zhang, X; Han, J; Ivy, Z; Njoku, F; Farooqui, M; Molokie, R; Gordeuk, V; Gladwin, M; Malik, P; Quinn, C; Saraf, S. Renin-angiotensin-aldosterone system inhibitors exacerbate anemia in sickle cell disease. Blood. 2025; 146(Supplement 1):297-297.

Parisi, R; Dhulipalla, S; Widemann, B; Pichard, DC; Gross, A; Weintraub, L. 61430 Dermatologic adverse events in neurofibromatosis patients on MEK inhibitors. Journal of American Academy of Dermatology. 2025; 93(3):ab33.

Perales, M-A; Riches, M; He, N; Martens, MJ; Chemaly, RF; Dandoy, CE; Hill, JA; Diaz, MA; Hashmi, S; Prockop, S; Lazarus, HM; Beitinjaneh, AM; Hildebrandt, GC; Auletta, JJ; Szabolcs, P. Delayed T-cell recovery after hematopoietic cell transplantation is associated with decreased overall survival in adults. Blood advances. 2025; 9(14):3502-3517.

Pereda Ginocchio, MA; Ramos, KN; Espinoza-Gutarra, MR; Ghalehsari, N; Pandey, M; Shah, R; Davies, SM; Gomez-Arteaga, A; Hall, AG. Understanding Diversity: An ASTCT-NMDP ACCESS Initiative Survey of the Hematopoietic Cell Transplant and Cellular Therapy Workforce in the United States. Transplantation and Cellular Therapy. 2025.

Perotti, D; O'sullivan, MJ; Walz, AL; Davick, J; Al-Saadi, R; Benedetti, DJ; Brzezinski, J; Ciceri, S; Cost, NG; Dome, JS; Spreafico, F; Geller, JI; Van Den Heuvel-Eibrink, MM; Hong, AL. Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers. Nature Reviews Urology. 2025; 22(8):526-543.

Perry, C; Eldem, I; Zarnegar-Lumley, S; Shliakhtsitsava, K; Cancio, M; Myers, K; Bhatla, D; Thota, S. Transition of care of youth with bone marrow failure conditions: Current practices, barriers, and burden- a survey of hematology-oncology providers in the US. Blood. 2025; 146(Supplement 1):4394.

Peshoff, MM; Zheng, J; Fei, M; Pallegar, PN; Lu, QR; Wu, L-J. TMOD-42. TREM2 modulates glioma-associated microglia and macrophage function in a genetic driver dependent manner. Neuro-Oncology. 2025; 27(Supplement_5):v483-v483.

Phelan, R; Rotz, S; Dandoy, CE; Auletta, JJ; Badia, P; Bhatt, NS; Ballard, SA; Blacken, R; Daraiseh, NM; Desmond, C; Pai, A; Tarquini, S; Fitch, TJ; Hartley, D. Multicenter Study on Caregiver Experiences in Pediatric Hematopoietic Stem Cell Transplantation: Part II. Treatment Challenges, Communication Barriers, and Caregiver-Driven Approaches to Mitigation. Transplantation and Cellular Therapy. 2025; 31(8):590.e1-590.e16.

Pommert, L; Tasian, SK. ‘Blin’-ing Is Winning for Children With B-Cell Acute Lymphoblastic Leukemia. The Hematologist. 2025; 22(1).

Potter, A; Sharma, N; Patel, K; Qureshi, MR; Khan, M; Wallace, C; Ziady, A; Ashfaq, A; Moore, C; Hayes, D. Persisting Inflammatory and Fibrotic Gene Signatures Linking Acute Cellular Rejection to Chronic Lung Allograft Dysfunction. American Journal of Transplantation. 2025; 25(8):s823-s824.

Potter, A; Sharma, N; Wallace, C; Ziady, A; Moore, C; Morales, D; Hayes, D. (750) Single Cell Technology Shines LIGHT on Acute Lung Allograft Dysfunction. The Journal of Heart and Lung Transplantation. 2025; 44(4):s355.

Potter, A; Sharma, N; Patel, K; Qureshi, M; Khan, M; Wallace, C; Ziady, A; Morales, D; Hayes, D. (276) Gene Expression Alterations in Lung Allografts with ACR and After Treatment Compared to Never ACR. The Journal of Heart and Lung Transplantation. 2025; 44(4):s140.

Power-Hays, A; Quinn, CT. Liquid Hydroxyurea (Xromi) for Children With Sickle Cell Anemia: A New Solution Compounding Existing Problems. Pediatric Blood and Cancer. 2026; e70143.

Power-Hays, A; Namazzi, R; Dong, M; Kazinga, C; Kato, C; Aliwuya, S; Mcelhinney, K; Conroy, AL; Lane, A; John, C; Vinks, AA; Latham, T; Opoka, RO; Ware, RE. The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial. British Journal of Clinical Pharmacology. 2025; 91(6):1865-1872.

Power-Hays, A; Namazzi, R; Dong, M; Kazinga, C; Kato, C; Aliwuya, S; Mcelhinney, K; Conroy, AL; Lane, A; John, C; Vinks, AA; Latham, T; Opoka, RO; Ware, RE. The feasibility of pharmacokinetic-based dosing of hydroxyurea for children with sickle cell anaemia in Uganda: Baseline results of the alternative dosing and prevention of transfusions trial. British Journal of Clinical Pharmacology. 2025; 91(6):1865-1872.

Power-Hays, A; Namazzi, R; Kato, C; Mcelhinney, KE; Conroy, AL; Hume, H; John, C; O'hara, SM; Stuber, SE; Lane, A; Latham, TS; Opoka, RO; Ware, RE. Pharmacokinetic-Guided Hydroxyurea to Reduce Transfusions in Ugandan Children with Sickle Cell Anemia: Study Design of the Alternative Dosing And Prevention of Transfusions Trial. Acta Haematologica. 2025; 148(2):208-219.

Power-Hays, A; Mcelhinney, KE; Williams, TN; Mochamah, G; Olupot-Olupot, P; Paasi, G; Reid, ME; Rankine-Mullings, AE; Opoka, RO; John, CC; Stuber, SE; Latham, TS; Vinks, AA; Ware, RE. Hydroxyurea pharmacokinetics in children with sickle cell anemia across different global populations. Blood advances. 2026; 10(2):418-427.

Power-Hays, A; Namazzi, R; Mcelhinney, K; Kincaid, A; Kato, C; Aliwuya, S; Opoka, R; Conroy, A; John, C; Hume, HA; Stuber, S; Latham, T; Ware, R. Full assessment of clinical transfusion support (FACTS): A prospective Study to determine the burden of sickle cell anemia on pediatric blood transfusion use in a malaria-endemic region in Africa. Blood. 2025; 146(Supplement 1):300-300.

Power-Hays, A; Kincaid, A; Mcelhinney, K; Latham, T; Quinn, C; Frenck, R; Ware, R. Measles vaccine-induced sero-protection among children with sickle cell anemia. Blood. 2025; 146(Supplement 1):1168.

Pressey, JG; Toebbe, B; Chandler, M; Szabo, S; Pitt, S. 23P Pre-diagnostic imaging reveals rapid emergence and progression of small cell carcinoma of the ovary hypercalcemic type (SCCOHT): Implications for monitoring carriers of SMARCA4 germline pathogenic variants (GPVs) ESMO Open. 2025; 10:104332.

Pruitt, DW; Bolikal, PD; Haas, M. Rehabilitation of the Pediatric Cancer Patient. In: Cancer Rehabilitation. Springer Publishing Company; 2025.

Pundavela, J; Hall, A; Dinglasan, SA; Choi, K; Rizvi, TA; Trapnell, BC; Wu, J; Ratner, N. Granulocyte-Macrophage Colony Stimulating Factor Receptor Contributes to Plexiform Neurofibroma Initiation. Cancers. 2025; 17(5).

Quinn, C; Kincaid, A; Mcelhinney, K; Korpik, J; Kalfa, T; Ware, R. Feasibility, reliability, and accuracy of point-of-care measurements of fetal hemoglobin. Blood. 2025; 146(Supplement 1):4739-4739.

Quinn, CT; Ware, RE. The modern use of hydroxyurea for children with sickle cell anemia. Haematologica. 2025; 110(5):1061-1073.

Quinn, CT; Ware, RE. The Voxelotor Effect: Decreased Affinity for New Drugs for Sickle Cell Disease? Pediatric Blood and Cancer. 2025; 72(3):e31475.

Ramos, KN; Ginocchio, MP; Gutarra, ME; Ghalehsari, N; Pandey, M; Shah, R; Davies, SM; Auletta, JJ; Arteaga, AG; Hall, AG. Perception and Reality of Racial and Ethnic Workforce Diversity in the U.S HCT/CT Workforce: Results from the ASTCT-NMDP Access Initiative Survey. Transplantation and Cellular Therapy. 2025; 31(2):s342.

Ramos, KN; Zee, J; Sabulski, A; Laskin, B; Blackard, JT; Langenberg, L; Dandoy, CE; Davies, SM; Jodele, S. Pre-Transplant Complement Activation and Transplant-Associated Thrombotic Microangiopathy (TA-TMA) across Diagnostic Groups. Transplantation and Cellular Therapy. 2025; 31(2):s25-s26.

Rangarajan, HG; Satwani, P; Herr, MM; Chen, M; Martens, MJ; Wudhikarn, K; John, S; Fabrizio, VA; Hsieh, EM; Kelkar, AH; Hill, JA; Huppler, A; Riches, M; Auletta, JJ. Real-world outcomes of infections following tisagenlecleucel in patients with B-cell ALL: a CIBMTR analysis. Blood advances. 2025; 9(21):5489-5500.

Rangarajan, HG; Chellapandian, D; Atshan, R; Ahn, KW; Kumar, S; Knight, TE; Leung, W; Ganguly, S; Williams, KM; Shah, NN; Qayed, M; Sharma, A; Broglie, L; Satwani, P. Impact of Extramedullary Disease at Diagnosis on Outcomes Post Allogeneic Hematopoietic Cell Transplant in Children and Young Adults With Acute Myeloid Leukemia: A CIBMTR Report. Transplantation and Cellular Therapy. 2025.

Raskin, S; Yang, C; Lin, T; Yearley, J; Blumenschein, W; Pillay-Smiley, N; Lenzen, A; Partap, S; Fangusaro, J; Gururangan, S; Onar-Thomas, A; Fouladi, M; Dunkel, I; Mitchell, D; Hwang, E. IMMU-79. An Updated Analysis of PD1 and Immune Pathway Activity in Malignant Pediatric Central Nervous System (CNS) Tumors: A Pediatric Brain Tumor Consortium (PBTC) Study, PBTC-N13. Neuro-Oncology. 2025; 27(Supplement_5):v221-v221.

Raskin, S; De Blank, P; Billups, CA; Li, Y; Olson, JM; Leary, SES. Isotretinoin has no effect on event-free survival across high-risk medulloblastoma molecular groups when added to maintenance: A secondary analysis of the Children's Oncology Group ACNS0332 data. Neuro-Oncology Advances. 2025; 7(1):vdaf054.

Raut, N; Adlakha, A; Sprague, KL; Rupert, AR; Hofmann, M; Ratner, N; Queme, LF; Jankowski, M. 137 Schwann Cell Glial Cell Line-Derived Neurotrophic Factor Signaling Influences Pain in Neurofibromatosis 1. Journal of Pain. 2025; 29:104935.

Rayes, A; Logan, BR; Liu, X; Dara, J; Buckley, RH; Oved, JH; Kapoor, N; Kapadia, M; Chandra, S; Martinez, CA; Heimall, J; Haddad, E; Pai, S-Y; Dvorak, CC. Outcomes Following Matched Sibling Donor Transplantation for Severe Combined Immunodeficiency: A Report from the PIDTC. Blood advances. 2025.

Reddoch-Cardenas, KM; Cancelas, JA; Nestheide, S; Rugg, N; Peña, K; Mcintosh, CS; Ferdin, J; Talackine, J; Parker, J; Jensen, LA; Gonzales, R; Hess, JR; Zia, M. Novel anticoagulant-preservative solution maintained the hemostatic function of cold stored whole blood for 56 days. Transfusion. 2025; 65 Suppl 1(Suppl 1):S185-S192.

Reed, HD; Brnich, S; Gudera, J; Ditroia, S; O’Donnell-Luria, A; Li, M-J; Yang, H; Brundige, K; Loveless, S; Cheng, L; Andresen, F; Fleming, M; Myers, K; Shimamura, A. GENETIC RE-EVALUATION OF SDS-LIKE AND NEUTROPENIA CONDITIONS. EJC Paediatric Oncology. 2025; 6:100400.

Reed, HD; Do, H; Weller, E; Harris, MH; Reilly, CR; Tsai, HK; Farrar, JE; Lau, BW; Pommert, L; Gamper, C; Cheng, L; Malsch, M; Myers, K; Shimamura, A. Lymphoid malignancies in patients with Shwachman-Diamond syndrome. Blood. 2025; 145(21):2528-2532.

Reinert, S; Benoit, SW; Nagarajan, R. Long-term kidney outcomes in survivors of Wilms tumor: a single-center retrospective cohort study. Pediatric Nephrology. 2025; 40(5):1603-1611.

Renfro, LA; Vallance, KL; Tfirn, IC; Evageliou, N; Benedetti, DJ; Shamberger, RC; Ehrlich, PF; Cost, NG; Aldrink, JH; Schechter, A; Fernandez, CV; Dome, JS; Geller, JI; Mullen, EA. Associations of Patient Age, Tumor Nephrectomy Weight, and Tumor Diameter with Event-Free and Overall Survival in Stage I or II Favorable Histology Wilms Tumor: A Pooled Analysis of Children's Oncology Group Studies AREN0532 and AREN03B2. Annals of Surgery. 2025.

Richmond, A; Hansen, S; Dykman, M; Adams, DM; Antaya, RJ; Bennett, JT; Frieden, IJ; Hammill, AM; Liang, MG; Maheshwari, M; Chamlin, S; Cotton, C; Lalor, L; Lee, LW. 44: Capillary Malformation-Arteriovenous Malformation Syndrome: Proposed Consensus Guidelines. Journal of Investigative Dermatology. 2025; 145(3):e12.

Riedl Khursigara, M; Benoit, S; Patriquin, CJ; Lemaire, M; Licht, C. Thrombotic Thrombocytopenic Purpura, Atypical Hemolytic Uremic Syndrome, and Spectrum of Thrombotic Microangiopathy. In: Pediatric Nephrology. Springer Nature; 2025:1-41.

Rineer, S; Kwakye, D; Ambrose, EE; Jason, IDP; Smart, LR. Validation of Pediatric Self-Report Pain Scales in Sub-Saharan Africa: A Systematic Review. Journal of Pain and Symptom Management. 2025; 69(2):e103-e112.

Rios, CR; Lu, M; Hanson, K; Savidge, E; Ward, T; Korpik, J; Reynaud, M; Ware, R; Kalfa, T; Quinn, C. Imaging flow cytometry for detection of red blood cell inclusions: A quantitative approach to assess splenic filtration function in sickle cell disease. Blood. 2025; 146(Supplement 1):1188.

Risinger, M; Zhang, W; Kalfa, TA. Advances on the genetic basis of red cell membrane disorders. Current Opinion in Hematology. 2025; 32(5):279-286.

Roome, RB; Yadav, A; Flores, L; Puarr, AK; Nardini, D; Richardson, A; Waclaw, RR; Arkell, RM; Menon, V; Johnson, JE; Levine, AJ. Ontogeny of the spinal cord dorsal horn. Science. 2026; 391(6781):eadx5781.

Rouce, RH; Dolan, JG; Phillips, CL; Qayed, M; Pulsipher, MA; Vernau, LM; Galletta, TJ; Votaw, S; Caraballo, GL; Yang, H; Tesfaye, M; Lee, S; O'sullivan, E; Grupp, SA. Kymriah Real-World Effectiveness and Functional Persistence in Acute Lymphoblastic Leukemia (ALL) (KareALL): A Retrospective Analysis of the Effect of Current Tisagenlecleucel (tisa-cel) Manufacturing in Pediatric and Young Adult Patients (pts) with ALL. Transplantation and Cellular Therapy. 2025; 31(2):s219.

Rubinstein, JD; Pham, G; Sridharan, A; Khoury, R; Wang, YM; Hudda, Z; Wilhelm, J; Lichtenstein, DA; Heyenbruch, D; Cancelas, JA; Davies, SM; Lutzko, C; Grimley, MS. Outcomes with third-party virus-specific T cells after the use of single-antigen cell lines to predict HLA restriction. Blood advances. 2025; 9(24):6305-6313.

Ruffolo, B; Vicente-Muñoz, S; Mehta, KY; Rivera-Cruz, CM; Zhao, X; Romick, L; Setchell, KDR; Lane, A; Wells, SI. The Fanconi Anemia Pathway Inhibits mTOR Signaling and Prevents Accelerated Translation in Head and Neck Cancer Cells. Cancers. 2025; 17(15).

Sabulski, A; Webster, A; Langenberg, L; Luebbering, N; Dandoy, CE; Koo, J; Jodele, S; Davies, SM. TA-TMA Evolution and Individual Susceptibility at the Proteome Level. Transplantation and Cellular Therapy. 2025; 31(2):s133.

Salamon, J; Widemann, BC; Gross, AM; Baldwin, A; Farschtschi, SC; Mautner, VF; Dombi, E. Malignant peripheral nerve sheath tumors in neurofibromatosis type 1 arise from distinct nodular lesions: A retrospective imaging analysis. Neuro-Oncology Advances. 2025; 7(1):vdaf201.

Sampson, M; Parker, L; Dandoy, CE; Auletta, JJ; Chapman, LR; Cook, E; Craddock, J; Culbertson, C; Daraiseh, N; Diaz, J; Snyder, AJ; Staton, S; Wall, SA; Badia, P. Variation in Central Venous Catheter Practices and Complications after Stem Cell Transplant: A Multi-Center Survey of the Engraft Learning Network. Transplantation and Cellular Therapy. 2025; 31(2):s535-s536.

Samra, S; Cook, E; Wilson, J; Sharma, M; Golding, L; Yao, DT; Marsh, RA; Turvey, SE. STAT6 gain-of-function disease: p.D519N is a new disease-causing variant that responds well to dupilumab treatment. Journal of Allergy and Clinical Immunology: Global. 2025; 4(3):100494.

Sarangdhar, M; Snyder, J; O'brien, E; Vancauwenbergh, B; Basu, M; Pressey, J; Perentesis, J. Abstract 3155: High-throughput drug repositioning identifies dinaciclib as a potent osteosarcoma inhibitor. Cancer Research. 2025; 85(8_Supplement_1):3155-3155.

Sargen, MR; Fitzhugh, MH; Ko, JS; Close, AG; Horton, SC; Malik, F; Furtado, LV; Bahrami, A; Seynnaeve, BKN; Pappo, AS; Gross, AM; Kaplan, R; Yohe, ME; Berrebi, KG. Clinicopathologic Features, Management, and Outcomes Of Pediatric CRTC1::TRIM11 and MED15::ATF1 Tumors With Spitzoid Morphology: A Case Series. Pediatric Blood and Cancer. 2025; 72(8):e31814.

Sawada, K; Khandelwal, P; Davies, SM; Crooker, A; Mizuno, T; Asai, A. Pharmacokinetic Monitoring of JAK Inhibitor and Tacrolimus for Safe and Effective Management of Graft-Versus-Host Disease After Pediatric Liver Transplantation. Pediatric Transplantation. 2025; 29(7):e70187.

Schmid, I; O’Neill, AF; Watanabe, K; Aerts, I; Branchereau, S; Brock, PR; Dandapani, M; Fresneau, B; Geller, J; Hishiki, T; Zsiros, J; Hiyama, E; Malogolowkin, M; Ansari, M. Global consensus from the PHITT consortium surrounding an interim chemotherapy guidance for the treatment of children with hepatoblastoma, hepatocellular neoplasm – not otherwise specified (HCN-NOS), hepatocellular carcinoma and fibrolamellar carcinoma after trial closure. EJC Paediatric Oncology. 2025; 5:100235.

Schoettler, ML; Gavriilaki, E; Carreras, E; Bo-Kyoung, C; Dandoy, CE; Ho, VT; Jodele, S; Moiseev, I; Sánchez-Ortega, I; Srivastava, A; Shaw, BE; Sureda, AM; Soiffer, R; Vasu, S. An ASTCT, CIBMTR, EBMT, and APBMT Consensus Statement Defining Response Criteria for Hematopoietic Cell Transplantation Associated Thrombotic Microangiopathy (TA-TMA) Directed Therapy. Transplantation and Cellular Therapy. 2025; 31(9):610-623.

Schrenk, S; Sherpa, C; Bischoff, LJ; Cai, Y; Boscolo, E. Semaphorin 3A and 3F Promote Lumen Expansion in TIE2-Mutated Venous Malformation. Arteriosclerosis, Thrombosis, and Vascular Biology. 2025; 45(12):2243-2260.

Schuemann, J; Rothwell, B; Mascia, A; Fan, Y; Loo, BW; Yock, T; Liu, KX; Perentesis, J; Haas-Kogan, DA. The potential and risks of FLASH radiotherapy in pediatric patients. Neuro-Oncology Pediatrics. 2025.

Schumacher, DJ; Michelson, C; Winn, A; Henry, D; O'connor, M; Li, S-TT; Blair, RJ; Velazquez-Campbell, M; Kihlstrom, MJ; Borman-Shoap, E; Kravtchenko, S; Jain, S; Vu, T; Schwartz, A. Graduating Residents' Readiness for Unsupervised Practice. Pediatrics. 2025; 155(5).

Schurer, A; Ilyas, H; Maron, M; Hegde, S; Leyden, M; Roy, I; Hyka, R; Dada, L; Shabanowitz, J; Hunt, D; Belizaire, R; Kitamura, S; Gritsman, K; Shechter, D. TTLL4 glutamyltransferase is a therapeutic target for NPM1-mutated Acute Myeloid Leukemia. Blood. 2025; 146(Supplement 1):869-869.

Schwarz, L; Cheng, L; Steltz, S; Schwarz, D; Korn, E; Loveless, S; Cooper, R; Dusa, C; Hornung, L; Howell, JC; Shimamura, A; Myers, KC; Koo, J. Growth Patterns in Shwachman-Diamond Syndrome: Findings from the North American Shwachman-Diamond Syndrome Registry. Journal of Pediatrics. 2025; 287:114780.

Segal, J; Cronk, J; Ball, B; Forbes, G; Jackett, K; Li, K; Osorno, AM; Montalvan, ESA; Browne, A; Lake, J; Kaplan, RN. Parallels in Canonical Developmental Signaling Pathways between Normal Development and the Tumor Microenvironment. Cold Spring Harbor Perspectives in Medicine. 2025.

Seither, K; Cortezzo, DE; Mckinney, D; Ricci, K; Riddle, S. Congenital Lymphatic Malformations. NeoReviews. 2025; 26(8):e578-e586.

Setayesh, T; Tijani, A; Kaur, H; Khanal, S; Zhu, Z; Chi, M; Kincaid, A; Ware, R; Malik, P. Oxidative stress and hemoglobin-c denaturation drive hemoglobin SC pathophysiology and can be ameliorated by antioxidants and hydroxyurea. Blood. 2025; 146(Supplement 1):7.

Setayesh, T; Chi, M; Oestreicher, Z; Sakabe, M; Seu, K; Zhu, Z; Kaur, H; Tijani, A; Xin, M; Shova, A; Balla, J; Vandenheuvel, K; Hu, Y-C; Malik, P. A novel mouse model of hemoglobin SC disease reveals mechanisms underlying beneficial effects of hydroxyurea. Blood. 2025; 146(1):13-28.

Shah, NC; Ngwube, A; Suresh, T; Sowa, A; Abraham, A; Anderson, E; Andreansky, M; Bhatia, M; Chaudhury, S; Cuvelier, GDE; Krishnamurti, L; Saini, S; Skiles, J; Shenoy, S. Impact of Abatacept Inclusive Graft-Versus-Host Disease Prophylaxis in Pediatric Stem Cell Transplantation for Hemoglobinopathy. Transplantation and Cellular Therapy. 2025; 31(10):826.e1-826.e10.

Sharma, A; O'brien, MM; Phillips, CL; Schultz, KR; Mehta, PA; Kebriaei, P; Vandendries, E; Dorman, S; Jiang, W; Zhang, F; Asomaning, K; Zhang, M-J; De Lima, MJG; Marks, DI; Saber, W. Sinusoidal obstruction syndrome and other outcomes in pediatric patients with acute lymphoblastic leukemia who received inotuzumab ozogamicin before hematopoietic cell transplantation. Journal of Clinical Oncology. 2025; 43(16_suppl).